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ABSTRACT 
 
 Pregnancy is a time of alternating states of inflammation. The 
establishment of pregnancy is marked by controlled inflammation and transition 
toward an anti-inflammatory state for much of the gestational period before 
returning to an inflammatory state at the onset of labor.  Stress and depression 
trigger the HPA Axis to produce cortisol and levels are maintained in a state of 
elevation during pregnancy and continue to rise before parturition.  
 The aim of this research was to explore the relationship of gestational age 
at delivery with mid-pregnancy levels of cytokines, stress and depression. 
Participant samples (N = 122) were collected between 16 and 26 weeks 
gestation and analyzed for 14 cytokines using a bead-based multiplex assay. 
Plasma cortisol was also measured along with demographic variables and 
measures of perceived stress and dysphoric mood.  
 Results of Pearson’s correlations showed that gestational age at delivery 
was significantly inversely correlated with pro-inflammatory cytokine IFN-γ and 
anti-inflammatory IL-13. A significant positive correlation was noted with the 
number of pregnancies in the obstetric history and pregnancy length. Both 
cortisol and stress were not correlated with gestational age at delivery. 
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CHAPTER ONE 
INTRODUCTION 
 
Background of Problem 
During pregnancy, activation of the immune system by inflammation and 
the Hypothalamic-Pituitary-Adrenal (HPA) axis by stress triggers the release of 
cytokines and hormones into the maternal-fetal circulation.  Responses to such 
events vary by individual, but could mark the start of a cascade of events leading 
to a spontaneous birth or a medically indicated induced delivery. The length of 
time that a woman is pregnant is often directly related to the health and mortality 
of a newborn infant.  
Compared with infants born at term, preterm infants have higher rates of 
disability and mortality (Behrman & Butler, 2007). Early delivery interferes with 
the fetus’ development in utero, resulting in immature (and often impaired 
functioning) vital body systems. A child born prior to 37 weeks gestation may not 
have fully developed lungs that are able to function properly to provide adequate 
oxygenation to support life or the body’s processes.  Prolonged pregnancies also 
carry risks which are usually associated with the increased size of the infant at 
birth. 
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While there is no single cause, the incidence of delivery at an early 
gestational age has been attributed to a combination of idiopathic causes, 
inflammation, over-distention of the uterus, and psychosocial variables such as 
maternal stress and depression during pregnancy.  Delivery prior to term 
development has long-lasting emotional and physical effects on the affected 
family, as well as an immense economic impact on the family and healthcare 
system. Similarly, the cause of post-term deliveries is not entirely understood but 
also poses harmful risks to the pregnant woman and fetus.  
 Just as there is no single cause for the early onset of labor and preterm 
delivery, one particular symptom does not precede its onset. Several conditions 
that may precede early labor and delivery are discussed in the literature. Vaginal 
infections have been noted in patients who have delivered prior to term (Hendler 
et al., 2007; Hitti et al., 2007) with the most common infection noted as bacterial 
vaginosis.  Vaginal bleeding during pregnancy has also been associated with a 
higher incidence of early delivery (Kim et al., 2005; Weiss et al., 2004).  Other 
conditions which contribute to a greater incidence of preterm delivery include 
stressful life conditions (Dasari & Kodenchery, 2007), a body mass index (BMI) 
greater than 30 (Kim, et al., 2005), and a history of induced abortion (Ancel, 
Lelong, Papiernik, Saurel-Cubizolles, & Kaminski, 2004; Moreau et al., 2005). 
Maternal stress may also play a role in controlling the length of gestation. 
The inclusion of stress in the maternal environment and how women process 
stressful stimuli may alone, or in combination with other variables, contribute to 
onset of labor.  During the body’s normal response to stress, it releases 
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corticotropin-releasing hormone (CRH) into circulation. Studies have shown that 
levels of stress in conjunction with CRH levels may be a predictor of gestational 
age at delivery (Hobel, Dunkel-Schetter, Roesch, Castro, & Arora, 1999; Ruiz, 
Fullerton, Brown, & Dudley, 2002). 
 The delicate balance of cytokines of the immune system during pregnancy 
has also been investigated for its role in influencing the length of gestation. 
Immune mechanisms vary and adapt throughout pregnancy depending on an 
individual’s genetic and environmental influences (Mor & Cardenas, 2010). An 
attack on the developing fetus by immune protectors resulting in a rise of 
inflammation could result in an early birth or miscarriage. 
Purpose 
The current investigation sought to examine the links between maternal 
physiological and psychological variables perceived stress, depressive 
symptoms, cytokines, and cortisol with gestational age at delivery. Biological 
markers of interest, such as maternal plasma levels of cytokines and cortisol, 
may aid in the early identification of women at risk for early delivery, or deliveries 
that extend beyond term. Figure 1 is a visual representation of the relationship of 
the variables of interest in the current study. The psychological variables, stress 
and depressive symptoms, may be related and the level of one may influence the 
level of the other. The presence of stress and depressive symptoms triggers the 
body’s physiological response and release of cortisol by the HPA axis and 
cytokines by the immune system. During pregnancy, this state may influence the 
gestational age at which labor is initiated and birth occurs.  
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Perceived Stress Depression
Physiological Response
HPA activation = cortisol elevation
Immune response = inflammatory cytokines
Affected Gestational 
Length
 Figure 1. Conceptual Framework 
 
Significance of Study 
Investigation is necessary to understand how gestational length is affected 
and identify methods of predicting women who are at risk for a pre- or post-term 
delivery. The utility of such findings will translate into preventive interventions and 
treatments, thus saving thousands of lives and preventing future disability in 
children.  This study builds on available findings, but is one of few investigations 
to explore mid-pregnancy plasma cytokine levels utilizing a multiplex, bead-
based assay analyzed with Luminex technology.   
Specific Aims and Research Questions 
This study focused on the evaluation of physiological and psychological 
variables and gestational age at delivery. Specifically, this investigator proposed 
to: 
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 Aim 1. Estimate the bivariate relationship between mid-pregnancy 
measures of physiological and psychological variables and gestational age at 
delivery. 
  Research Question 1: To what extent are mid-pregnancy maternal 
  plasma cytokines correlated with gestational age at delivery? 
  Research Question 2: To what extent are mid-pregnancy maternal 
  plasma cortisol levels correlated with gestational age at delivery? 
  Research Question 3: To what extent are mid-pregnancy  
  perceived stress scores correlated with gestational age at delivery? 
  Research Question 4: To what extent are mid-pregnancy   
  depressive symptom scores correlated with gestational age at  
  delivery? 
 Aim 2. Examine the unique role played by physiological and psychological 
variables in predicting gestational age at delivery in a multivariate multiple 
regression model.  
Definition of Terms 
The following terms have been defined for the purposes of this study: 
 Apgar score is a summed rating assessment (0 to 2 per item) of a 
newborn infant based on five items: heart rate, respiratory effort, reflex irritability, 
muscle tone and color (Apgar, 1953). The assessment is completed at one 
minute after birth and repeated again at five minutes to assess for change in 
condition.  The five minute Apgar score is a strong indicator of infant survival 
after birth (Cunningham et al., 2010). 
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 Cytokines are “regulatory proteins secreted by white blood cells and a 
variety of other cells in the body; the pleiotropic actions of cytokines include 
numerous effects on cells of the immune system and modulation of inflammatory 
responses” (Thomson & Lotze, 2003, p. 5). 
 Gestational length (or gestational age) refers to the length of time that a 
woman is pregnant.   It is often calculated by using the date of a woman’s last 
menstrual period as the beginning of her pregnancy and may be confirmed by 
other means such as the use of ultrasound (Behrman & Butler, 2007). 
 Gravida refers to the number of times that a woman has been pregnant. 
 Medically indicated birth refers to the delivery of an infant prior to the 
spontaneous onset of labor due to risk for or presence of medical complications. 
 Nulliparity refers to a woman who has not previously given birth to a child. 
 Parturition is defined as the “bringing forth of young” (Cunningham, et al., 
2010); the process of giving birth to offspring. 
  Postterm birth occurs at 42 weeks (294 days) gestation or greater 
(Brazelton, 1984). 
 Preterm birth may occur as early as 20 weeks (140 days) (Creasy & Iams, 
1999) and prior to 37 weeks (259 days) gestation (Mathews & MacDorman, 
2008). 
 Spontaneous birth is the natural onset of labor leading to delivery of the 
infant. 
 Term birth is defined as a pregnancy with delivery of the infant occurring 
between 37 and 41 weeks gestation (Mathews & MacDorman, 2008).   
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Chapter Summary 
Chapter one provides an introduction to the problem and establishment of 
the significance of the study. Alterations in gestational length of pregnancy may 
have detrimental effects on families and the healthcare system, therefore 
establishment of effective means of identifying women at risk for shortened or 
prolonged pregnancy may provide an opportunity for intervention and prevention. 
The current study sought to examine the links between levels of maternal stress, 
depressive symptoms, cytokines, and cortisol with gestational age at delivery. 
Relationships among these variables, if established, may be utilized as markers 
of risk. 
Chapter two will provide an overview of the physiological changes during 
pregnancy and explain the role of the immune system.  Conditions which may 
contribute to alterations in gestational length will be examined. Relevant literature 
will be reviewed. 
8 
 
 
 
 
CHAPTER TWO 
REVIEW OF LITERATURE 
 
 This chapter presents a review of the literature relevant to this study.  
Topics include an overview of the physiological mechanisms associated with 
pregnancy with an emphasis placed on identifying alterations among a 
pregnancy characterized as normal and that which has been complicated by 
various conditions affecting gestational length. An introduction to basic 
immunology has been included to establish a general understanding of cytokines 
and their function. To further support the hypothesized relationship between 
maternal cytokines, stress, and depressive symptoms with gestational age at 
delivery, the effect of cytokine, stress and depression levels on pregnancy 
outcome are also discussed.   
Physiological Mechanisms of the Normal Pregnancy 
 Adaptations of the maternal body systems. The female body 
undergoes many changes as it prepares for conception, maintenance of 
pregnancy, parturition, and return to the non-pregnant state.  Besides the 
obvious transformation in physical appearance, each body system of the 
pregnant female undergoes alterations throughout pregnancy to keep up with the 
demands of the developing fetus.  
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 The most notable changes to the maternal reproductive system are the 
expansion in the size of the uterus and increased uterine blood flow.  The uterus 
in the non-pregnant state weighs about 70 grams with a total cavity volume of 10 
milliliters or less.  At term, the pregnant uterus can reach up to 1100 grams in 
weight and total volume of five to 20 liters (Cunningham, et al., 2010).  
 Uterine blood flow is vitally important to the survival of the fetus. Blood 
flow to the uterus provides for adequate perfusion of the placenta which is the 
means of delivering oxygen, essential nutrients, and removal of waste from the 
fetus (Cunningham, et al., 2010; Torgersen & Curran, 2006). Factors that impact 
uterine blood flow including medical conditions such as hypertensive disorders, 
diabetes mellitus, and post-date gestation can have a detrimental effect on fetal 
development and survival (Torgersen & Curran, 2006).  
 In order to accommodate the increased blood flow to the uterus, placenta, 
and fetus and prepare for the loss of blood after delivery, the hematologic system 
must adapt by increasing the maternal volume of blood (Cunningham, et al., 
2010; Torgersen & Curran, 2006). Although this state of hypervolemia varies per 
individual, blood volume increases (on average) 48 percent during pregnancy 
with a marked increase occurring during the second trimester. Pregnancies in 
women challenged with megoblastic anemia or severe gestational hypertension 
may not appreciate the same expansion in blood volume as that in a normal 
pregnancy thus impairing the ability to tolerate blood loss at parturition (Pritchard, 
1965). 
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 Pregnancy affects metabolism of proteins, carbohydrates, and fats in 
response to the demands placed by the fetus on the mother.  The maternal basal 
metabolic rate may increase 10 to 20 percent by the third trimester of pregnancy 
resulting in increased energy demands and caloric consumption (Cunningham, et 
al., 2010). Weight gain during pregnancy is the result of the expanding size of the 
uterus and its contents, increased blood and extracellular fluid volume, and 
additional stores of maternal fat and water in the body.  
 Studies have demonstrated that pre-pregnancy weight, as well as weight 
gained during pregnancy, are related to infant weight at birth (Cunningham, et al., 
2010; Heude et al., 2011) and the risk for developing complications during 
pregnancy (Heude, et al., 2011).  Low weight gain during pregnancy presents an 
increased risk for preterm delivery while the risk of gestational hypertension and 
diabetes is greater in women with a high pre-pregnancy body mass index (BMI) 
(Heude, et al., 2011). 
 The endocrine system functions to regulate the body by secreting 
hormones into the bloodstream.  One of the earliest examples of this function 
during pregnancy is the pituitary’s secretion of growth hormone.  Maternal 
secretion of pituitary growth hormone into circulation is later replaced by 
placental growth hormone during pregnancy (Cunningham, et al., 2010).  
Findings by Mittal et al. (2007) support the relationship between placental growth 
hormone with fetal growth and the development of preeclampsia.  In their study, 
women with preeclampsia had higher levels of placental growth hormone than 
women experiencing a normal pregnancy.  Among women with preeclampsia, 
11 
 
lower levels of placental growth hormone were measured in women delivering 
infants who were small for gestational age than those delivering infants of 
average size. 
 The most important function of the maternal immune system to note is the 
suppression of a Th1 response and upregulation of Th2 cells.  This  balance is in 
contrast to the non-pregnant state, but vital to prevent rejection of the fetus (i.e. 
miscarriage) (Thellin & Heinen, 2003) or risk development of pregnancy related 
complications such as preeclampsia (Jonsson et al., 2006). An overview of the 
immune system and the immune system during pregnancy is described later. 
 Parturition.  Four phases comprise parturition which begins at the point 
of conception and ends when fertility is restored and the woman is once again 
able to achieve pregnancy.  In the normal pregnancy, Phase One (Quiescence) 
is characterized by a softening of the cervix while maintaining its structure 
(competence) and the absence of dilation. Ninety-five percent of the pregnancy is 
spent in this phase. Phase Two (Activation) is the period during which the body 
prepares for labor.  This occurs during the last six to eight weeks of pregnancy 
and includes active changes in the uterus. The ripening of the cervix includes 
changes in connective tissue leading to further softening and thinning allowing for 
the passage of the fetus through the birth canal.  Phase Three (Stimulation) 
includes all of the processes associated with labor; uterine contractions, cervical 
dilation, and delivery of the fetus and placenta.  The final phase, Phase Four 
(Involution), is the recovery phase leading to a restored state of fertility. Phase 
Four begins immediately after the placenta is delivered and may last four to six 
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weeks (or longer if breastfeeding). During this time, the uterus and cervix return 
to the prepregnant state and fertility is restored once ovulation begins again 
(Cunningham, et al., 2010). 
 Alterations of these four phases may lead to difficult deliveries, preterm 
labor, or post-term delivery. An incompetent cervix, one that is dilating and 
thinning prematurely, may lead to miscarriage or preterm delivery.  Owen and 
colleagues (2001) reported that a noted thinning, or shortening, in cervical length 
on ultrasound can be noted as early as 16 weeks gestation in women who will 
experience spontaneous preterm birth.  
Complications in Pregnancy Affecting the Length of Gestation 
Gestational length (or gestational age) refers to the time which has passed 
since the first day of the last menstrual period to the day of birth.  For humans, 
the average length of a pregnancy is 40 weeks (280 days) (Cunningham, et al., 
2010), however a term gestation includes births occurring  between 37 and 41 
completed weeks gestation (Fleischman, Oinuma, & Clark, 2010).  During this 
time, the fetus undergoes a major transformation beginning with the union of the 
haploid gametes to form a diploid zygote, formation of functioning body systems, 
and growth from mere millimeters up to 14 to 20 inches at full term. 
Shortened gestational length. Shortened gestational length interferes 
with the fetus’ development of mature body systems vital for life outside of the 
womb. Immature neurological, immune, respiratory, urinary, and gastrointestinal 
systems leave the fetus at risk for numerous complications including infection 
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and death.  A number of factors, a few of which are presented here, contribute to 
a shortened gestational length resulting from a birth prior to term. 
 Spontaneous abortion (miscarriage). Among known 
pregnancies, spontaneous abortion affects 15 to 20 percent of women, primarily 
in the first trimester of pregnancy.  In addition to other variables, factors which 
may contribute to the occurrence of spontaneous abortion are advanced 
maternal age, previous history of miscarriage or ectopic pregnancy (outside of 
the uterus), maternal tobacco use, and chromosomal abnormalities (de la 
Rochebrochard & Thonneau, 2002). Failure to maintain a Th2 balanced state in 
pregnancy may also contribute to increased inflammation and subsequent attack 
on the developing non-self fetus leading to miscarriage. 
 Preterm labor and birth. It is estimated that 12.3 percent of all live 
births in the United States occur preterm (Martin et al., 2010) contributing to total 
healthcare costs of over $26 billion in the United States alone (Institute of 
Medicine, 2007). Prematurity is a leading cause of death in the first month of life 
and the percentage of preterm-related infant deaths continues to rise annually 
(Mathews & MacDorman, 2008). A major contributor to illness and disability 
among infants in this population, preterm birth can lead to developmental delays, 
chronic respiratory problems, and problems with vision and hearing. If the child 
survives beyond birth and infancy, affected families may be faced with the 
emotional, physical, and financial challenges of caring for a child with lifelong 
illness and disability. 
14 
 
There are four main reasons for a preterm delivery: (a) medically indicated 
induced vaginal or cesarean delivery for maternal or fetal indications (i.e. 
preeclampsia, placental abruption, fetal distress), (b) spontaneous preterm labor 
with intact membranes, (c) preterm premature rupture of the membranes 
(PPROM), and (d) multifetal gestation (Cunningham, et al., 2010; Goldenberg, 
Culhane, Iams, & Romero, 2008). Medically indicated deliveries account for 30 to 
35 percent of preterm births, 40 to 45 percent result from spontaneous preterm 
labor, and PPROM accounts for 25 to 30 percent of preterm deliveries 
(Goldenberg, et al., 2008). Among pregnancies in the United States in 2008, a 
preterm delivery resulted from 10.6 percent of singleton pregnancies compared 
to 58.9 percent of twin pregnancies and 92.2 to 95.7 percent of triplet and higher 
order pregnancies (Martin, et al., 2010). Increased stretch of the uterus, greater 
production of corticotropin-releasing hormone (CRH), and elevated surfactant 
levels in the amniotic fluid resulting from a multifetal gestation may contribute to 
the disparate preterm rates compared to singleton pregnancies (Stock & 
Norman, 2010). 
Research has focused on identifying causes, predictive biological 
markers, and interventions for preventing delivery prematurely. Despite a 
growing body of knowledge about the potential pathways (i.e. inflammation, 
Hypothalamic-Pituitary-Adrenal (HPA) axis activation, hemorrhage, and uterine 
distension), the exact cause of preterm delivery still remains unclear. These 
pathways often occur simultaneously, however the presence of inflammation and 
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activation of the HPA axis by stress account for the largest percentage (~70 
percent) of preterm births (Lockwood & Kuczynski, 2001). 
 Gestational hypertension and preeclampsia. Gestational 
hypertension is a condition that occurs during pregnancy in the previously 
normotensive individual.  It manifests after 20 weeks gestation and is no longer 
present after postpartum recovery. Gestational hypertension is characterized by 
measurement of a systolic blood pressure of 140mmHg or greater and diastolic 
blood pressure of 90mmHg or higher (American College of Obstetricians and 
Gynecologists, 2002). 
 Preeclampsia is a condition characterized by the changes in blood 
pressure as described above with the addition of 300mg of protein excretion in 
the urine in a 24-hour period. The condition affects five to nine percent of 
pregnancies. Preeclampsia may result in blood flow impairment to the placenta 
and lead to fetal intra-uterine growth restriction (IUGR), oligohydramnios 
(decreased amniotic fluid), placental abruption (placental lining separates from 
uterus before birth), and impaired fetal well-being.  The maternal condition may 
be further complicated by the onset of seizures (eclampsia) and the development 
of HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelets). The 
only treatment for this condition is delivery of the placenta which unfortunately 
may result in a preterm delivery (American College of Obstetricians and 
Gynecologists, 2002). 
 The onset of preeclampsia appears to be the result of multiple intersecting 
factors.  Some of the causes include, but are not limited to, abnormal 
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trophoblastic invasion of the uterine arteries during implantation (Kharfi et al., 
2003), an abnormal maternal immune response to paternal and fetal antigens, 
and genetic factors (Cunningham, et al., 2010).  
 Extended gestational length. A post-term pregnancy is one that extends 
beyond the length of a term gestation.  According to the American College of 
Obstetricians and Gynecologists (2004), a pregnancy which has extended to or 
beyond 42 weeks of gestation (294 days) is considered to be post-term. In a 
review by Divon and Feldman-Leidner (2008), the authors indicate that an 
estimated four to 19 percent of pregnancies may reach or exceed 42 weeks 
gestation. In 2008, 5.7 percent of all live births in the United States reached or 
exceeded 42 weeks gestation (Martin, et al., 2010). 
 Although the factors that influence the occurrence of a post-term delivery 
are not entirely known, some known influences include a previous experience of 
a post-term pregnancy (Mogren, Stenlund, & Hogberg, 1999), pregnancy with a 
male fetus (Divon, Ferber, Nisell, & Westgren, 2002), and genetic factors 
(Olesen, Basso, & Olsen, 2003).  Additionally, a high pre-pregnancy BMI and 
nulliparity (never given birth before) may also contribute (Caughey, Stotland, 
Washington, & Escobar, 2009; Olesen, Westergaard, & Olsen, 2006). 
 Pregnancy prolonged beyond term carries a significant risk to both mother 
and child.  For the mother, a post-term delivery puts her at risk for labor dystocia 
(abnormal or difficult labor) and injury to the perineum resulting from the passage 
of a large baby.  A post-term birth also carries an increased chance for a 
cesarean delivery which is associated with endometritis (inflamed or irritated 
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uterine lining), hemorrhage, and the development of blood clots which can block 
the flow of blood in arteries and veins (American College of Obstetricians and 
Gynecologists, 2004).   
 For the fetus, a prolonged pregnancy is associated with an increased risk 
of stillbirth, neonatal mortality, and post-neonatal mortality (Hilder, Costeloe, & 
Thilaganathan, 1998). Post-term infants risk passage of meconium (feces 
accumulated in the fetal intestines) in utero and then subsequent aspiration upon 
delivery leading to respiratory complications. They also risk development of 
neonatal acidemia (low umbilical artery blood pH) (Kitlinski, Kallen, Marsal, & 
Olofsson, 2003), oligohydramnios, distress/non-reassuring heart rate of the fetus 
during labor (Doherty & Norwitz, 2008), low Apgar scores, macrosomia (large for 
gestational age/increased birth weight), and injury during delivery (Doherty & 
Norwitz, 2008; Spellacy, Miller, Winegar, & Peterson, 1985). Post-term delivery 
has also been associated with a greater risk for developing cerebral palsy 
(Moster, Wilcox, Vollset, Markestad, & Lie, 2010) and lower cognitive 
development (Yang, Platt, & Kramer, 2010). 
The Immune System in the Non-Pregnant State 
 The immune system is the body’s defense against toxins, bacteria, 
cancer, and other infectious threats (Doan, Melvold, Viselli, & Waltenbaugh, 
2008). Primary organs of the immune system include the bone marrow and the 
thymus while secondary organs are the lymph nodes, spleen, tonsils, adenoids, 
appendix, and Peyer’s patches of the intestine (Moser & Leo, 2010). Three major 
defense mechanisms of the immune system include: (a) external barriers 
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(physical and chemical/biological), (b) the innate immune system, and (c) the 
adaptive immune system (Doan, et al., 2008; Moser & Leo, 2010).  
 An important function of the immune system is to recognize that which is 
self versus non-self. Self refers to cells, molecules, and tissues encountered 
during immune surveillance which contain recognition markers on their surfaces 
that are identified as belonging within the body.  Under normal conditions, the 
body’s immune system does not attack cells, molecules, and tissues identified as 
self.   Non-self cells and molecules are viewed as foreign invaders of the body 
and will trigger the immune system to attack and eliminate the non-self from the 
body (Doan, et al., 2008). 
 The innate and adaptive immune responses. The first lines of defense 
against infection are the physical and chemical/biological barriers of the immune 
system.  These barriers work to prevent or impair foreign cells and molecules 
from invading the body.  Physical barriers include the skin, mucous membranes, 
respiratory tract, and urinary tract. The acidic pH of the stomach is an example of 
a chemical barrier preventing bacteria from invading.  Another example of a 
chemical barrier is the presence of lysozyme in sweat and tears. Lysozyme 
contains an enzyme used to eliminate most bacteria by its ability to break down 
bacterial cell walls (Doan, et al., 2008). During pregnancy, the mucus plug serves 
as a physical and chemical barrier preventing entrance into the uterus via the 
vaginal canal (Hein, Petersen, Helmig, Uldbjerg, & Reinholdt, 2005). 
 If foreign cells move beyond the external barriers, then the innate immune 
response is next in line to protect the body. The innate immune system employs 
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an immediate (within a few hours), non-specific response to foreign invaders and 
uses pattern recognition receptors (PRR) to distinguish self from non-self.  These 
PRRs recognize structures (pathogen-associated molecular patterns – PAMPs) 
on bacteria, viruses, parasites and other invaders that are not found on host cells 
or tissues.  Binding of PRRs to the PAMPs triggers the launch of the innate 
immune response which involves the activation of the complement pathway, 
attack of phagocytic cells (cells that engulf and destroy) and activation of Natural 
Killer (NK) cells to destroy the body’s invader. Activated phagocytes (such as 
macrophages, dendritic cells, and neutrophils) secrete cytokines (i.e. 
interleukin(IL)-1, IL-6, IL-8, IL12, and tumor necrosis factor(TNF)-α) and 
chemokines that produce inflammation, attract other immune cells to the site of 
the infection, and eventually activate the adaptive immune response (Dempsey, 
Vaidya, & Cheng, 2003; Doan, et al., 2008; Moser & Leo, 2010).   
 Unlike the innate immune response, the adaptive immune response is 
specific, develops with each exposure to foreign cells, and then creates a 
memory to that exposure. The specificity of its role results in a delayed response 
of up to 10 days. Memory results in specific immunity to the particular disease 
and a more rapid response to the disease if exposed again. The adaptive 
immune system relies on the recognition of foreign antigens on the surface of 
invading cells to identify non-self. A specific T cell or B cell with a matching 
antigen receptor is activated to respond and eliminate the threat (Elgert, 2009). 
 Cytokines. The relationship between cells, cytokines, and other biological 
agents is complex.  First, cytokines are described as being pleiotropic, meaning a 
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single cytokine may have multiple target cells and multiple actions. Second, the 
actions of different cytokines are often redundant and therefore actions cannot be 
attributed to a single cytokine.  Next, exposure of a cell to several cytokines may 
have a synergistic or antagonistic effect leading to quantitatively different 
responses.  Also, a cytokine may increase (or decrease) the production of 
another cytokine. Finally, a cytokine may increase (or decrease) the expression 
of and signaling by receptors for other cytokines and growth factors (Thomson & 
Lotze, 2003). 
 Cytokines are often characterized by their secretion from different T helper 
(Th) lymphocytes.  The Th1 cytokines (i.e. IFN-γ and IL-2) are related to cell-
mediated immunity (primarily phagocyte dependent involving macrophages, NK 
cells, and cytotoxic T-lymphocytes; not antibodies) and inflammation. Cytokines 
of the Th2 group (e.g. IL-4, IL-5, IL-6, IL-10, IL-13) are associated with antibody-
mediated humoral immunity. The antagonistic relationship between Th1 and Th2 
cytokines results in the inhibition of Th2 cytokines by Th1 cytokines and vice 
versa. Th2 cells are inhibited by IFN-γ while IL-4 and IL10 inhibit Th1 cells 
(Fitzgerald, O'Neill, Gearing, & Callard, 2001) 
 The predominance of either a Th1 or Th2 cytokine subset has been 
helpful in explaining the underlying mechanisms of various human diseases. For 
example, a Th1 dominance is associated with many autoimmune diseases 
(Balkwill, 2000).  In contrast, pregnancy has been long described as a Th2 
phenomenon where successful pregnancies tend to be associated with greater 
Th2 cytokines and elevations in Th1 cytokines may have detrimental effects on 
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pregnancy outcome (Wegmann, Lin, Guilbert, & Mosmann, 1993). This shift 
toward a Th2 profile in pregnancy may also explain why women with cell-
mediated autoimmune diseases such as rheumatoid arthritis demonstrate a 
remission of their symptoms during pregnancy. 
 Table 1 (at end of chapter) provides an overview of cytokines related to 
the current study.  It identifies the source of cytokine secretion and the actions of 
the cytokine. This is not an all inclusive list of all cytokines, nor does it provide 
complete details on all sources and actions. 
The Immune System During Pregnancy 
 The immune system during normal pregnancy. Even in the absence of 
complications, the body of a pregnant female undergoes much change in order to 
prevent rejection of the developing fetus. To prevent the body from viewing the 
fetus as a foreign invader (non-self), the maternal immune system must be 
modified. Alterations in both adaptive and innate immune mechanisms vary 
throughout  pregnancy, depending on stage, exposures to certain 
microorganisms, preexisting diseases, and pathophysiological processes that 
might occur during the pregnancy (Mor & Cardenas, 2010).  
 Wegmann et al. (1993) first described pregnancy as a Th2-like 
phenomenon and possible adverse pregnancy outcomes, such as miscarriage, 
could result from a shift in cytokine balance toward a Th1 state. Recent research 
has partially supported Wegmann’s theory in that a great majority of pregnancy is 
characterized by a Th2, or anti-inflammatory, state. In a recent review by Mor 
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and Cardenas (2010), they describe three distinct phases in pregnancy 
characterized by a shift in cytokine balance. 
 The first phase includes the period of implantation, placentation and the 
first and early second trimesters of pregnancy.  They associate this period with 
an “open wound, … a veritable battleground of invading cells, dying cells, and 
repairing cells.”  While the woman’s body adjusts to the presence of the fetus, it 
remains in a pro-inflammatory state. This state of inflammation is evidenced by 
maternal symptoms such as nausea. 
 The second phase includes the second and third trimesters of pregnancy.  
During this time, cytokines have shifted toward an anti-inflammatory state. 
Maternal symptoms from inflammation have subsided and the mother and fetus 
live in harmony as the fetus is rapidly growing and developing. Delivery of the 
fetus (stage three) is characterized by the return of the pro-inflammatory state.  
Inflammation is achieved by activated immune cells in the myometrium and 
subsequent contraction of the uterus. Therefore, normal pregnancy is a state of 
shifting cytokine balance from a pro-inflammatory to an anti-inflammatory state, 
and return to a pro-inflammatory state at delivery. 
 Few studies have detailed the shifting levels of cytokines in maternal 
serum or plasma during a normal pregnancy.  Recent completed studies vary 
greatly in sample size from less than 30 participants (Makhseed et al., 2000; 
Vassiliadis, Ranella, Papadimitriou, Makrygiannakis, & Athanassakis, 1998) to a 
larger study including over 1200 participants (Curry et al., 2008).  Results are not 
congruent for all cytokines across studies. 
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 Several studies have reported stable levels of TNF-α throughout 
pregnancy (Curry, et al., 2008; Makhseed, et al., 2000; Vassiliadis, et al., 1998).  
Increased levels of IFN-γ (Curry, et al., 2008; Vassiliadis, et al., 1998), IL-12 
(Curry, et al., 2008), and granulocyte-macrophage colony-stimulating factor (GM-
CSF) (Vassiliadis, et al., 1998) were recorded in some investigations while others 
found no significant differences during pregnancy for levels of IFN-γ (Makhseed, 
et al., 2000) and IL-12 (Vassiliadis, et al., 1998) and decreased levels of GM-
CSF (Curry, et al., 2008).  Levels of IL-6 were shown to increase, but at varying 
points during pregnancy; after the first trimester (Curry, et al., 2008; Vassiliadis, 
et al., 1998), after 24 weeks gestation (Curry, et al., 2008), and at the time of 
delivery (Makhseed, et al., 2000).  During labor, IL-10 was detected at greater 
concentrations, but was otherwise stable throughout pregnancy (Makhseed, et 
al., 2000; Vassiliadis, et al., 1998). 
 Curry, et al. (2008) explored the relationship between cytokines and 
maternal variables during early- and mid-gestation of normal pregnancy.  Their 
findings revealed that early levels of GM-CSF were lower in women with a Body 
Mass Index (BMI) below 18.5.  Early levels of TNF-α, IL-2, IL-6, and IFN-γ were 
elevated in women age 35 years or older.  Socioeconomic level, smoking status, 
and gravidity were not shown to be related to cytokine levels during their 
investigation. These results indicate that maternal factors influence cytokine 
levels in the normal, healthy pregnancy and may contribute to the shift in balance 
of the Th1 and Th2 state. 
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 The immune system and complications affecting gestational length. 
Table 2 (at end of chapter) summarizes recent investigations published on serum 
or plasma measures of cytokines and pregnancies complicated by preterm labor, 
threatened or spontaneous abortion (miscarriage), and preeclampsia.  
 Preterm birth. In a review of 50 human studies of cytokines and 
their association with preterm birth published prior to April 2008, Lyon, et al. 
(2010) concluded that the most consistent finding across all studies was an 
increase in levels of pro-inflammatory cytokines.  In particular, this included 
increased levels of IL-6, IL-1β, and TNF-α in preterm maternal serum samples 
verses term.  In comparing recent studies on maternal serum or plasma 
cytokines and their relationship to preterm birth, inconsistencies in the timing of 
sample collection, methods used for cytokine analysis, and cytokine variables of 
interest make comparisons across studies challenging and conclusions difficult to 
formulate. For example, the timing of venipuncture may occur as early as six 
weeks gestation and up to 37 weeks gestation. Cytokine levels may be 
measured by Luminex technology (Ekelund et al., 2008; Kramer et al., 2010; 
Vogel et al., 2007), enzyme-linked immunosorbent assay (ELISA) (Hudic et al., 
2009; Laudanski, Lemancewicz, Pierzynski, Akerlund, & Laudanski, 2006; 
Mercer et al., 2006; Pearce et al., 2008; Vitoratos, Papadias, Makrakis, et al., 
2006; Whitcomb, Schisterman, Luo, & Chegini, 2009), or flow cytometry (Curry et 
al., 2009).  
  Pre-eclampsia. Saito, et al. (2007) summarized published findings 
supporting the relationship between preeclampsia and an altered immune state.  
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First, preeclampsia occurs more often in primigravid (first pregnancy) women or 
multigravid women with a new partner.  Subsequent pregnancies with the same 
partner decrease the rate of preeclampsia indicating maternal recognition of 
paternal antigens and immune adaptation. Next, exposure to semen over an 
extended period of time appears to decrease the risk of preeclampsia.  Effective 
exposure to paternal antigens in the seminal fluid may be by vaginal or oral 
contact. The risk of developing preeclampsia is very high (16 to 33%) when a 
woman receives a donated ovum or embryo as the donated products are foreign 
to the woman’s body. Finally, the rates of preeclampsia are low in women with 
HIV who have T cell immune deficiency. 
Preeclampsia is marked by the presence of elevated inflammatory 
proteins. In recent reported studies of women with preeclampsia, TNF-α, 
(Cackovic et al., 2008; Canakci et al., 2007; Laskowska, Leszczynska-Gorzelak, 
Laskowska, & Oleszczuk, 2006), IL-1β (Canakci, et al., 2007), IL-6 (Jonsson, et 
al., 2006), IL-8 (Jonsson, et al., 2006; Laskowska, Laskowska, Leszczynska-
Gorzelak, & Oleszczuk, 2007), IL-16 (Hu, Wang, Wang, Huang, & Dong, 2007), 
IL-18 (Huang, Huang, Dong, Yao, & Wang, 2005; Seol et al., 2009), and 
macrophage migration inhibitory factor (MIF) (Todros et al., 2005) were 
increased as compared to levels in normal, healthy controls.  Interestingly, there 
is a decrease in the concentration of TNF-α in the urine of women with elevated 
serum levels of TNF-α (Cackovic, et al., 2008). The authors pose the question 
about whether serum values are affected by increased production of TNF-α in 
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circulation or decreased filtration and clearance by the kidneys.  This is an area 
of further investigation. 
 Miscarriage. Similarly, increased inflammation is also seen in 
cases of spontaneous abortion. Pro-inflammatory IL-1β and TNF-α are elevated 
in women with threatened abortion and subsequent miscarriage as compared to 
women who carried their pregnancy to completion (Vitoratos, Papadias, 
Makrakis, et al., 2006). This may indicate a shift toward a Th1-type response and 
inflammation incompatible with successful pregnancy.   
Identification of novel cytokine markers in maternal serum/plasma would 
provide a feasible means of identifying women at risk for inflammation associated 
complications in pregnancy. Among recent studies of preterm birth, spontaneous 
abortion, and preeclampsia, TNF-α was shown to be significantly elevated in 
cases versus controls across all conditions.  A significant rise in IL-6 was 
commonly shared in cases of preterm birth and preeclampsia; and was elevated 
in spontaneous abortion and preeclampsia. Further investigation with human 
subjects is needed to completely understand the Th1/Th2 dynamic in pregnancy 
and parturition and more specifically in conditions leading to adverse pregnancy 
outcomes. 
These three cytokines commonly found to be elevated, IL-1β, IL6, and 
TNF-α, are all proinflammatory cytokines indicating a possible association 
between these conditions and an increased state of inflammation. As previously 
mentioned, two of the four potential pathways to early delivery include 
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inflammation and HPA Axis activation which account for approximately 70 
percent of preterm deliveries (Lockwood & Kuczynski, 2001).  
Psychological Stress and Depression During Pregnancy 
 The term stress carries meaning that is different among most individuals. 
As a noun, stress may take on a negative meaning such as “ a physical, 
chemical, or emotional factor that causes bodily or mental tension and may be a 
factor in disease” (Merriam-Webster, 2011). Stress may also take action as a 
verb as in, to place emphasis on something.  Selye (1976, p. 15) defined stress 
as “the non-specific response of the body to any demand for change.”  In his 
description, stress may have a desirable (eustress) effect or undesirable 
(distress) influence on an individual. 
 The body’s response to stress is complex and involves the interaction 
between the nervous, immune, endocrine, cardiovascular, and metabolic 
systems in positive and negative feedback loops.  Whenever the body 
encounters stress, good or bad, it will initially respond in the same manner. The 
stressful stimuli will stimulate the HPA Axis beginning with the release of 
corticotropin-releasing hormone (CRH) from the hypothalamus. The anterior 
pituitary is triggered by CRH to release adrenocorticosteroid hormone (ACTH) 
which then acts on the adrenal glands to secrete cortisol into circulation. The 
feedback loops help the body to terminate the stress response when the stressful 
situation is no longer present. The rise in cortisol negatively influences the 
hypothalamus to cease from secreting CRH.  Figure 2 provides a basic 
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Figure 2.  Hypothalamic-Pituitary-Adrenal (HPA) Axis in response to stress. Stress 
triggers the release of CRH which acts on the pituitary to release ACTH and 
subsequently the adrenal glands to release cortisol into circulation.  Solid lines represent 
positive feedback and dashed lines are negative feedback relationships. 
 
 During pregnancy, however, the placenta also produces CRH (pCRH) 
(see Figure 3). The relationship of cortisol to pCRH is in contrast to that which is 
produced in the hypothalamus.  A rise in cortisol during pregnancy increases the 
production of pCRH (Sandman, Davis, Buss, & Glynn, 2011). There is a steady 
rise in pCRH and managed state of hypercortisolemia during pregnancy. 
Sufficient levels of CRH binding protein (CRH-BP) manage the circulating levels 
of pCRH.  In the final weeks of pregnancy, CRH-BP levels decrease as pCRH 
levels continue to rise in excess influencing the onset of parturition (McLean et 
al., 1995; Wadhwa, Porto, Garite, Chicz-DeMet, & Sandman, 1998). 
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Figure 3. Effect of stress on the HPA Axis and immune mediators during pregnancy. In 
contrast to CRH from the hypothalamus, placental CRH stimulates the release of ACTH 
and cortisol into circulation.  Solid lines indicate positive feedback and dashed lines 
indicate negative feedback relationships. 
 
 Numerous studies have investigated the relationship between CRH levels 
and the timing of parturition. In a study of 485 women recruited in their first 
trimester of pregnancy, McLean et al. (1995) concluded that pCRH is a marker of 
gestational length and measurement of maternal plasma CRH between 16 and 
20 weeks gestation may help identify women who will deliver at term, preterm, 
and postterm. Significant elevations of CRH early in pregnancy (~20 weeks 
gestation) have been shown to be present in women who experience preterm 
labor (Hobel, Dunkel-Schetter, et al., 1999) and gestational hypertension (Hobel, 
Arora, & Korst, 1999). Sandman and colleagues (2006) also support the 
relationship in the rise of pCRH and the onset of labor.  In their study, however, 
only CRH levels at 31 weeks gestation were predictive of preterm birth.  
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Additionally, they reported that elevated cortisol levels at 15 weeks gestation 
predicted the excessive rise in CRH leading to shortened gestation. 
 As discussed, physiological measures (e.g. hormones of the HPA Axis) 
have been investigated to describe the role that stress plays in predicting 
gestational length.  Psychological measures may also serve as a useful tool.  
The challenge with psychological measures is the varying definitions of stress.  
Previous studies conducted during pregnancy have utilized various measures for 
stress including levels of anxiety (Hobel, Dunkel-Schetter, et al., 1999), work 
stress (Lee et al., 2011), and perceived stress (Krabbendam et al., 2005) 
 Perceived stress measures an individual’s appraisal of their life’s stressors 
(Cohen, Kamarck, & Mermelstein, 1983). In pregnancy, a reduction of perceived 
stress over the course of the pregnancy has been inversely related to gestational 
length.  Measures of perceived stress in conjunction with CRH levels have been 
shown to be predictive of gestational age at delivery (Hobel, Dunkel-Schetter, et 
al., 1999; Ruiz, et al., 2002). 
 Prenatal depression is a significant problem as depressed women are 
more likely to experience preterm labor, preeclampsia, diabetes, Cesarean 
section, anemia, and infections during labor. Infants born to depressed women 
are also at greater risk for fetal growth restriction, abnormalities, distress, and 
death (Bansil et al., 2010). Depression has been found to be positively related to 
preterm delivery (Fransson, Ortenstrand, & Hjelmstedt, 2011; Phillips, Wise, 
Rich-Edwards, Stampfer, & Rosenberg, 2010; Smith, Shao, Howell, Lin, & 
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Yonkers, 2011) and cortisol elevation has been noted in women with prenatal 
depression (Field & Diego, 2008; O'Keane et al., 2011). 
 Chapter Summary 
 Chapter two provided a review of literature related to the topic of study 
and provided an overview of the physiological changes which occur during 
pregnancy.  Pregnancy may be impacted by conditions such as preterm labor, 
spontaneous abortion, and gestational hypertension which may interfere with the 
successful pregnancy ending at term. Research has demonstrated that maternal 
levels of perceived stress and depression can negatively impact the outcome of 
pregnancy. 
 Stress triggers the stress response which involves the HPA Axis. Levels of 
CRH, which are normally secreted from the hypothalamus, are exponentially 
increased during the course of gestation due to the concurrent production of 
CRH in the placenta.  Additionally, while cortisol has a negative influence on 
CRH secretion from the hypothalamus in the non-pregnant individual, placental 
CRH is further secreted in the presence of cortisol.  This is important to note as 
cortisol levels rise in response to HPA activation by stress. Thus, stress 
experienced during pregnancy may increase levels of circulating CRH which has 
been referred to as the “placental clock”, a trigger for the onset of labor. 
 While there are numerous variables to consider that may affect the 
gestational length of pregnancy (the outcome variable), the current variables 
under study were chosen based on a review of the literature and data obtained to 
complete a secondary data analysis.  Figure 4 summarizes the independent 
32 
 
variables (inputs) and the dependent variable (output). First, we will consider the 
influence that certain maternal characteristics (i.e. age, race, ethnicity, and 
gravida) have on the length of gestation. Second, the influence of maternal 
depressive symptoms and perceived stress (psychological variables) will be 
investigated.  Finally, physiological measures of maternal plasma cytokine and 
cortisol levels will also be considered. 
 A detailed description of the study method executed in the current study 
has been described in Chapter three. Further information about the source of the 
data for the secondary analysis has been discussed. 
 
Patient Characteristics
•Age
•Race
•Ethnicity
•Gravida
Psychological Variables
•Depression - (Profile of Mood States)
•Stress - (The Perceived Stress Scale)
Physiological Variables
•Stress Hormone – (Cortisol)
•Inflammatory Cytokines – (GMCSF, 
MCP1,TNFα, IFNγ, IL1β, IL2, IL4,  
IL5, IL6, IL7, IL8, IL10, IL12, IL13
Gestational Length 
of Pregnancy
Figure 4. Input and Output Variables under Study 
 
33 
 
TABLE 1. Overview of cytokine source and function 
Cytokine Sources Action 
GM-CSF T cells, macrophages, fibroblasts, and 
endothelial cells 
Growth factor for haematopoietic progenitor cells; activating factor for 
granulocytic and monocytic cells; growth factor for several cells including T cells 
IFN- γ CD8+ and CD4+ T cells, NK cells Involved in nearly all phases of immune and inflammatory responses; activation, 
growth, and differentiation of T cells, B cells, macrophages, NK cells, and 
others.  Hallmark of Th1 differentiation 
IL-1 β A variety of cells including monocytes, 
macrophages, dendritic cells, T lymphocytes, 
B lymphocytes, and NK cells 
Induces fever, hypotension, weight loss, neutrophilia, and acute phase response 
IL-2 T cells Stimulates growth and differentiation of T cells, B cells, NK cells, LAK cells, 
monocytes, macrophages, and oligodendrocytes 
IL-4 T cells, mast cells, eosinophils, and basophils Effects on B cells, T cells, nonlymphoid cells including monocytes, endothelial 
cells and fibroblasts; induces secretion of IgG4 and IgE 
IL-5 Mast cells, T cells, eosinophils Stimulates eosinophils colony formation and is an eosinophil differentiation 
factor 
IL-6 T cells, B cells, and nonlymphoid cells such as 
macrophages, bone marrow stromal cells, and 
endothelial cells 
Regulates B and T cell function, hematopoiesis and acute phase reactions 
IL-7 Bone marrow, thymic stromal cells, and spleen 
cells 
Growth factor for progenitor B cells and T cells; also stimulates proliferation and 
differentiation of mature T cells 
IL-8 Multiple cells including monocytes, 
lymphocytes, granulocytes, and endothelial 
cells 
Inflammatory chemokine; functions as neutrophil chemoattractant and activating 
factor.  Also attracts basophils, and some lymphocytes. 
IL-10 Th0 and Th2 subsets of CD4+ T lymphocytes; 
T-reg cells 
Blocks activation of cytokine synthesis by Th1 T cells, activated monocytes, and 
NK cells; stimulates proliferation of B cells, thymocytes, and mast cells 
IL-12 B lymphoblastoid cells, dendritic cells (most 
potent producers), and B cells 
Induces IFN-γ production by T cells and NK cells, enhances NK activity, and 
induces differentiation of the Th1 subset of T lymphocytes 
IL-13 Activated Th2 cells, mast cells, and NK cells Important in Th2 response; upregulation of IgE; suppression of inflammatory 
response; inhibits production of inflammatory cytokines (IL-1β, IL-6, TNF-α, IL-8) 
MCP-1 Produced by wide range of tissues; 
upregulated by proinflammatory stimuli such 
as IFN-γ 
Monocyte chemoattractant and activating factor for monocytes, basophils, T 
cells, NK cells, and immature dendritic cells 
TNF- α Activated monocytes and macrophages and 
other cells including B cells, T cells, and 
fibroblasts 
Mediator of inflammatory and immune functions; regulates growth dna 
differentiation of  a variety of cell types 
Note. CD = cluster of differentiation; NK = Natural Killer; LAK = lymphokine activated killer; IgG = Immunoglobulin G; IgE = Immunoglobulin E 
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TABLE 2. Recent cytokine research related to preterm birth, miscarriage, and preeclampsia 
Year Author(s) Sample Cytokines Studied Outcome 
Preterm Labor and Preterm Birth 
2010 (Lyon, et al., 
2010) 
**State of the Science – 
Integrated Review 
 
Human studies for association of 
cytokines in blood with preterm 
birth (PTB) 
Pro-inflammatory – IL1β, IL6, IL8, 
IL11, IL12, IL17, IL18, TNFα, IFNγ 
Anti-inflammatory – IL4, IL10, IL13, 
IL16, IFNα, TGFβ 
 
Colony Stimulating Factors –  
G-CSF, GM-CSF, M-CSF 
 
Most consistent finding = 
increased level of 
proinflammatory cytokines, 
particularly IL6, IL1β, TNFα 
associated with PTB 
*Relatively few studies and 
results not consistent 
 
2010 (Kramer, et 
al., 2010) 
Spontaneous preterm delivery 
(sPTD) (n=207) and term 
controls (n=444) 
 
frozen plasma samples collected 
prospectively at 24-26 weeks 
gestation prior to onset of 
preterm labor (PTL) 
IL1β, IL4, IL5, IL6, IL8, IL10, IL12, 
IL17, IL18, sIL6ra, IFNγ, TNFα, 
TNFβ, sTNFrI, MCP1, TGFβ, MIP1a, 
MIP1B, MIF, MMP9, TREM1, 
RANTES, BDNF, NT3, NT4, GM-
CSF, CRP 
 
cytometric sandwich assay with 
Luminex 
 
High MMP-9 concentrations 
associated with PTB 
2009 (Curry, et al., 
2008) 
sPTD – early 24-29 weeks 
(n=107), moderate 30-33 weeks 
(n=353), and late 34-36 weeks 
(n=422); term (n=1372). 
 
Plasma collected prospectively 
during 1st trimester (≤ 16 weeks 
- - median 8 weeks) 
IL2, IL6, TNFα, INFγ, GM-CSF 
 
Measured with flow cytometry 
Elevated TNFα and GM-CSF 
associated with increased risk 
of delivery at 34-36 weeks. 
sPTD <34 weeks associated 
with elevated IL6 and TNFα in 
underweight women. Elevated 
IL2 and TNFα reduced risk of 
delivery <34 weeks in obese 
women.  **Cytokines not related 
to delivery <34 weeks in normal 
and overweight women. 1st 
trimester cytokine levels and 
risk of PTD may depend on pre-
pregnancy BMI. 
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Year Author(s) Sample Cytokines Studied Outcome 
2009 (Whitcomb, 
et al., 2009) 
Normal pregnancy (n=394) and 
PTB (n=31) 
 
Serum collected prospectively in 
1st and 2nd trimester between 6-
18 weeks (during years 1959-
1966) 
 
G-CSF 
 
Measured by sandwich ELISA-based 
approach 
Higher serum levels of G-CSF 
6-18 weeks (greater risk if 
elevated 11-18 weeks) 
significantly associated with 
gestational age at delivery and 
PTB.   
2009 (Hudic, et al., 
2009) 
Threatened PTD (n=30) and 
healthy pregnant women (n=20) 
 
serum collected prospectively at 
24-37 weeks gestation after 
hospitalization for threatened 
PTD (case) and control collected 
24-37 weeks with no risk factors 
for PTD 
Progesterone Induced Blocking 
Factor (PIBF) – a protein released by 
lymphocytes during pregnancy in 
presence of progesterone.  
Progesterone thought to establish 
adequate immune environment, IL10, 
IL6, TNFα, IFNγ 
 
Measured by ELISA 
 
PIBF lower in preterm subjects; 
lower IL10 in preterm, higher 
IL6 and IFNγ in preterm 
2008 (Ekelund, et 
al., 2008) 
Threatened PTD (n=93) 
admitted for PTL, PPROM, or 
cervical ripening 
Serum collected on admission to 
hospital with threatened PTD 
between 24 weeks and <34 
weeks (during years 1997-1999) 
IL12 and L18 reported here, but also 
IL1β, IL2, IL4, IL5, IL6, IL8, IL10, 
IL17, sIL6ra, TNFα, TNFβ, sTNFR1, 
IFNγ, GM-CSF, MMP9 
Measured by 15-plex sandwich assay 
with Luminex 
Correlations between low levels 
of IL18 and PTD; women 
delivering before 34 weeks had 
lower IL18 than women >34 
weeks; Women with IL18 level 
<95pg/ml had 3-fold increased 
risk of delivering before 34 
weeks 
 
No difference in IL12 levels in 
those delivering <34 or >34 
weeks 
 
Possible interaction – patients 
with low IL18 and high IL12 had 
increased risk of delivery <34 
wks 
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Year Author(s) Sample Cytokines Studied Outcome 
2008 (Pearce, et 
al., 2008)  
Preterm (n=60) and term 
(n=122) 
 
Serum collected prospectively 
between 9-23 weeks 
Macrophage migration inhibitory 
factor (MIF) – soluble mediator that 
helps govern interaction between 
cytokines and stress hormones (i.e. 
cortisol) 
 
Measured by sandwich ELISA 
 
MIF elevated in PTD cases 
 
High MIF associated with 
maternal risk-taking behavior 
2007 (Vogel, et al., 
2007) 
Asymptomatic pregnant women    
12-25 weeks gestation with at 
least 1 prior sPTD between 16-
30 weeks 
IL1β, IL2, IL5, IL6, IL8, IL12, IL18, 
TNFα, TGFβ, sTNFR1, GM-CSF, 
TREM1 
 
Measured by xMAP technology with 
Luminex 
Serum IL1β, IL2, IL5, IL6, IL8, 
IL12, IL18, TNFα, TGFβ, 
sTNFR1, GM-CSF, and TREM1 
individually associated with 
sPTB. 
 
Stepwise linear model = high 
serum TNFα, high 
cervicovaginal sIL6Ra, and 
short cervical length contributed 
to prediction of PTB <35 weeks 
(false positive 5% able to 
predict 69% 
 
2006 (Mercer, et 
al., 2006) 
Included were women with 2 or 
3 completed pregnancies 
(including current) delivering at 
20 or more weeks divided into 3 
groups: Recurrent sPTD (2 or 3 
consecutive sPTD with no term 
births (TB)) (n=47), isolated 
sPTD (1 sPTD and 1 or 2 TB) 
(n=241), recurrent term birth (2 
or 3 consecutive TB and no 
sPTD) (n=969) 
 
Plasma collected prospectively 
at 22-24 weeks 
 
Inflammatory Cytokines – IL1β, IL6, 
IL10 
 
Stress marker – CRH and cortisol 
 
Measured with ELISA 
Cortisol and CRH higher in 
isolated PTB and recurrent PTB 
than in recurrent TB. 
 
Cytokines not increased in 
either isolated sPTD or 
recurrent sPTD. 
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Year Author(s) Sample Cytokines Studied Outcome 
2006 (Laudanski, 
et al., 2006) 
Preterm labor (PTL) who 
delivered (n=17), preterm 
pregnancy not in labor (n=13), 
and labor at term (n=8) 
 
Serum collected 26-36 weeks for 
those in labor and delivered 
preterm and those not in labor 
and delivered term; collected 
>37 weeks for those in labor at 
term 
 
 
Chemokines – MDC/CCL22, 
TARC/CCL17, ITAC/CXCL11, I-
309/CCL1, IP-10/CCL10, MIP-
1a/CCL3, -1B/CCL4, -3a/CCL20, -
3B/CCL19 
 
Measured with multiplexed, mini-
array, sandwich-type ELISA 
 
MIP-3B/CCL19 significantly 
lower in PTD group than other 2 
groups. 
2006 (Vitoratos, 
Papadias, 
Makrakis, et 
al., 2006) 
PTL (n=30) and normal control 
(n=19) 
 
Serum collected from PTL group 
upon presentation to hospital 
with symptoms of PTL >24 and 
≤34 weeks; normal group 
collected at clinic appointment 
>24 and =34 weeks. 
 
 
 
Corticotropin-releasing hormone 
(CRH) and TNFα 
 
CRH and TNFα measured with 
ELISA 
PTL group had higher CRH 
levels and TNFα than normal 
group.  
 
Positive correlation between 
CRH and TNFα in both groups 
but correlation stronger in PTL 
group. 
 
Threatened Abortion/Miscarriage 
2009 (Barrientos 
et al., 2009)  
Subsequent spontaneous 
abortion (SA) (n=42) and normal 
pregnancy (n=42) 
 
Serum collected prospectively 
between 4 and 12 weeks 
Asymmetric IgG antibodies (AAb) 
Indoleamine 2,3-dioxygenase (IDO) 
Cytokines – IL4, IL12, TNFα, and 
IFNγ 
 
IgG antibodies measured with ELISA 
Cytokines measured by sandwich 
ELISA 
 
 
 
Levels of IL10, IL12, and IDO 
activity were lower in SA cases 
but not significantly lower 
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Year Author(s) Sample Cytokines Studied Outcome 
2008 (Whitcomb et 
al., 2008) 
Miscarriages (n=439) and 
controls (n=373) 
 
Serum collected prior to report of 
miscarriage (loss < 140 days) at 
entry into study and bimonthly 
but not less than 10 days prior to 
miscarriage 
 
Samples collected between 
years 1959 and 1974 
 
IL1ra, IL1β, IL4, IL6, IFNγ, TNFα, 
thrombopoietin (TPO), G-CSF 
Increased risk of miscarriage 
associated with elevated levels 
of TPO 
2007 (Whitcomb et 
al., 2007) 
Miscarriages (n=439) and 
controls (n=373) 
 
Serum collected prior to report of 
miscarriage (loss < 140 days) at 
entry into study and bimonthly 
but not less than 10 days prior to 
miscarriage 
Chemokines (CC type) – MIP1a, 
MIP1B, MCP1, RANTES 
 
Chemokines (CXC type) – IL8, ENA-
78 
 
Chemokines measured with 
Fleurokine MAP Multiplex Human 
Cytokine Panel with Luminex 
 
 
ENA-78 levels associated with 
increased risk of miscarriage as 
collection-outcome interval 
increased in those samples 
collected >35 days prior to 
pregnancy outcome 
2006 (Vitoratos, 
Papadias, 
Economou, 
et al., 2006) 
Three groups: (1)Threatened 
Aborters (TA) discharged after 
resolution with viable fetus 
(n=31), (2)TAs with subsequent 
loss (n=22), (3)asymptomatic 
controls (n=22) 
 
Serum samples 7-10 weeks 
gestation collected once on 
admission (groups 2 and 3) or 
twice (group a on admission and 
discharge) 
 
 
IL1β, TNFα, IL6 
 
Measured by ELISA 
IL1β and TNFα significantly 
higher in TAs with subsequent 
loss.  No difference in levels of 
IL6 
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Year Author(s) Sample Cytokines Studied Outcome 
2006 (Kalinka & 
Radwan, 
2006) 
Threatened Aborters (TA) 
(n=27) and control (n=16) 
 
2 Serum samples collected 
between 6 and 12 weeks 
gestation  
 
TNFα, IL12, IL10 
 
Measured by ELISA 
Cytokines did not differ in TA 
group and normal group at first 
and second sampling 
Pre-eclampsia 
2009 (Seol, et al., 
2009) 
Preeclampsia (n=24) and 
healthy pregnant controls (n=13) 
 
Serum collected from case 
group in 3rd trimester after 
admission to hospital for 
preeclampsia and before 
delivery.  Serum from control 
group collected before elective 
csection or induction at term 
without labor 
Pro-inflammatory cytokine IL18 – 
may promote atheroslcerotic plaque 
formation 
 
Chitinase-like glycoprotein YKL-40 – 
inflammatory marker r/t extracellular 
remodeling and angiogenesis, 
elevated in acute and chronic 
inflammation. 
 
Both measured with ELISA 
 
 
 
YKL-40 levels significantly 
elevated in preeclampsia 
 
Median IL18 higher in 
preeclampsia group. 
 
YKL-40 higher in patients with 
more severe proteinuria may be 
related to severity of disease 
2008 (Montagnana 
et al., 2008) 
Preeclamptic women (n=14), 1st 
trimester normotensive women 
(n=20), 2nd trimester 
normotensive women (n=20), 3rd 
trimester normotensive women 
(n=17), non-pregnant women 
(n=21) 
 
Serum collection 
TNFα, IL1, IL6, IFNγ 
 
Measured by multiplexed sandwich 
ELISA 
Concentrations of TNFα lower 
than sensitivity limit of 
detection. 
 
IL1 and IL6 increased 
significantly in 2nd and 3rd 
trimester normotensive 
pregnancy 
 
Results of this study do not 
support screening for TNFα, 
IL6, IL1, or IFNγ for 
preeclampsia  
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Year Author(s) Sample Cytokines Studied Outcome 
2008 (Cackovic, et 
al., 2008) 
Severe Preeclampsia (n=45) 
and healthy controls (n=45) 
Serum and urine samples 
collected at same time as clinical 
assessment or admission to 
hospital 
TNFα 
 
Measured with ELISA 
Serum TNFα elevated in 
preeclampsia group 
Women with severe 
preeclampsia had significantly 
reduced fractional excretion of 
TNFα.  Urinary levels of TNFα 
were decreased in 
preeclampsia group. *Fractional 
excretion helps to understand if 
elevated serum levels are 
caused by increased production 
or decreased excretion. 
 
**therefore – impaired urinary 
clearance may contribute to 
elevation of serum levels of 
TNFα 
 
2007 (Borekci, 
Aksoy, Al, 
Demircan, & 
Kadanali, 
2007) 
Mild preeclampsia (n=38), 
severe preeclampsia (n=20), 
eclampsia (n=11), normotensive 
controls (n=20) 
 
Serum collected prior to planned 
c-section, induction of labor, or 
active labor.  Collected within 24 
hours of birth in 72% of patients 
and 48 hours of birth in 28%.  
Samples collected within 12 
hours of convulsions in patients 
with eclampsia 
IL2, IL6, IL10 
 
Measured with ELISA 
Mean concentrations of IL2 and 
IL6 were not different between 
groups. 
 
Median concentrations of IL10 
in mild and severe 
preeclampsia were similar and 
significantly lower than controls 
and patients with eclampsia 
 
Median concentrations of IL10 
significantly lower in eclampsia 
than all other groups. 
 
*Pre-eclampsia associated with 
deficient IL10.  High serum IL10 
correlated with presence of 
eclampsia 
 
41 
 
Year Author(s) Sample Cytokines Studied Outcome 
2007 (Canakci, et 
al., 2007) 
Mild preeclampsia (n=20), 
severe preeclampsia (n=18), 
healthy pregnant (n=21) 
Gingival cervicular fluid (GCF) 
and serum collected 48 hours 
prior to delivery 
 
IL1β, TNFα 
 
Prostaglandins (PGE2) 
Serum IL1β, TNFα, and PGE2 
measured with ELISA 
IL1β, TNFα, and PGE2 levels in 
serum and GCF were 
significantly higher in pre-
eclamptic women than normal 
controls 
 
Serum TNFα influenced by 
severity of preeclampsia 
 
2007 (Hu, et al., 
2007) 
Severe Preeclampsia (n=22), 
Mild preeclampsia (n=15) and 
normal controls (n=36). 
 
Serum samples collected after 
onset of preeclamptic symptoms 
 
IL15 and IL16 
 
IL15 measured by chemiluminescent 
immunoassay  
 
IL16 measure by ELISA 
Levels of IL15 and IL16 
significantly higher in 
preeclampsia than controls 
 
IL15 and IL16 significantly 
higher in severe preeclampsia 
than mild preeclampsia 
indicating IL15 and IL16 
associated with severity. 
 
2007 (Laskowska, 
et al., 2007) 
Preeclampsia with normal fetal 
weight (n=15), preeclampsia 
with intrauterine growth 
restriction (IUGR)  (n=12), 
normal controls (n=10) 
Serum from mothers collected 
before active labor phase.  
Umbilical cord serum collected 
immediately after delivery. 
 
IL8 – strong neutrophil 
chemoattractant and activator 
 
Measured by sandwich ELISA 
Increased IL8 found in both 
preeclamptic patient groups 
compared to control group 
 
Umbilical cord concentrations 
tended to be higher than 
maternal blood concentrations 
2006 (Laskowska, 
et al., 2006) 
Preeclampsia with normal fetal 
weight (n=18), preeclampsia 
with IUGR (n=8), normal 
controls (n=18) 
 
Serum from mothers collected 
before active labor phase. 
Umbilical cord serum collected 
immediately after delivery. 
TNFα 
 
Measured with sandwich ELISA 
Higher maternal and umbilical 
serum TNFα levels in severe 
preeclampsia 
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Year Author(s) Sample Cytokines Studied Outcome 
2006 (Bachmayer, 
Rafik 
Hamad, 
Liszka, 
Bremme, & 
Sverremark-
Ekstrom, 
2006) 
Preeclamptic women (n=22) and 
healthy controls (n=24) 
 
Serum collected when mothers 
arrived to delivery unit 
 
Also looked at deciduas natural 
killer (NK) cells and placental 
expression of cytokines 
NK cell activating cytokines – IL12, 
IL15, IL18 
 
Anti-inflammatory cytokines – IL10 
 
 
Serum cytokines measured by 
sandwich ELISA 
Due to insufficient amount of 
material – all cytokines could 
not be measured in all people 
 
IL12 significantly elevated in 
severe and mild cases versus 
controls. 
 
IL15 significantly elevated in 
severe cases versus controls. 
 
IL18 did not differ per group 
No significant differences in 
IL10 
 
 
2006 (Jonsson, et 
al., 2006) 
Moderate or Severe 
Preeclampsia (n=15) and normal 
controls (n=15)  **due to 
insufficient sample volume, not 
all measures were complete on 
all cytokines/chemokines 
 
Serum samples collected after 
diagnoses and admission to the 
hospital for preeclamptic group.  
Control group samples collected 
in antenatal clinic at pregnancy 
week matching case group. 
Cytokines and chemokines - IL1β, 
IL2, IL4, IL5, IL6, IL8, IL10, IL12 
p40, IL13, IL17, IFNα, IFNγ, GM-
CSF, MIP1a, MIP1B, MCP1, eotaxin, 
RANTES 
 
Measured with Luminex 
 
Soluble CD14 and soluble IL4 
receptor measured with ELISA 
 
 
IL13 not detectable in any 
samples 
 
Higher serum concentrations of 
pro-inflammatory cytokine IL6 in 
preeclamptic group. 
 
Elevated levels of pro-
inflammatory chemokines IL8 in 
preeclamptic group. 
 
**Elevated IL6 and IL8 support 
hypothesis of increased 
inflammatory response in 
preeclampsia 
 
Higher serum soluble IL4 
receptor in preeclamptic 
patients 
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Year Author(s) Sample Cytokines Studied Outcome 
2005 (Bersinger & 
Odegard, 
2005) 
Mild Preeclampsia (PE) without 
fetal growth restriction (n=23), 
Fetal growth restricted (FGR) 
without Preeclampsia (n=9), 
matched controls at 17, 25, and 
33 weeks gestations (n=40) 
 
Serum collected prospectively at 
17 and 33 weeks.  25 week 
sample collected on 12 cases in 
PE group, 6 cases in FGR 
group, and all 40 controls. 
 
 
 
 
M-CSF, VEGF, and placental growth 
factor (PLGF) 
 
All measured with ELISA 
 
 
VEGF did not differ between PE 
group and controls at any time 
point tested, but FGR group 
was significantly lower 
throughout. 
 
No significant differences in  
M-CSF levels between groups 
at any gestational age 
2005 (Huang, et 
al., 2005) 
Mild preeclampsia (n=13), 
severe preeclampsia (n=14), 
and normal controls (n=28) 
 
Serum and placental samples 
from women in 3rd trimester with 
elective c-section prior to labor 
Pro-inflammatory cytokine IL18 
 
Measured by ELISA 
Serum and placental IL18 
significantly higher in 
preeclampsia than controls 
 
Preeclamptic women who 
delivered before or after 36 
weeks had comparable serum 
and placental IL18 levels. 
 
Preeclamptic women who 
delivered after 36 weeks had 
significantly higher serum and 
placental IL18 levels than 
controls 
 
IL18 levels not significantly 
different between mild or severe 
preeclampsia 
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Year Author(s) Sample Cytokines Studied Outcome 
2005 (Kaleli et al., 
2005) 
Preeclamptic women (n=14) and 
normal controls (n=14) 
 
Serum collected around 34 
weeks gestation 
Neoptern and IL2R  
 
Neoptern measured with ELISA 
 
IL2R measured with Immulite 
analyzer 
Neopterin and IL2R levels 
significantly higher in women 
with preeclampsia than normal 
controls. 
 
Neopterin and IL2R levels 
significantly higher in women 
with severe preeclampsia. 
 
Results indicate a Th1-type 
immune mechanism in 
pathogenesis of preeclampsia 
 
2005 (Todros, et 
al., 2005) 
Severe preeclampsia delivering 
<34 weeks, Severe 
preeclampsia delivering ≥34 
weeks, 41 term controls, 41  
non-pregnant women 
 
Serum collected at time of 
vaginal delivery or before  
c-section 
 
 
Proinflammatory cytokine – Migration 
Inhibitory Factor (MIF) 
 
Measured by colorimetric sandwich 
ELISA 
MIF significantly higher in 
preeclamptic patients than 
control 
 
MIF significantly higher in 
preeclamptic patients who 
delivered <34 weeks than those 
who deliver ≥34 weeks. 
 
*High MIF supports role of 
inflammation in pathogenesis 
on disease 
 
MIF similar in normal pregnancy 
and non-pregnant controls 
Note. Cytokines and chemokines highlighted in bold text indicate they were included in the current study
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CHAPTER THREE 
METHOD 
 
Sample 
 This study was a secondary analysis of data collected as part of a larger 
longitudinal investigation of stress, immunity and thyroid disease in pregnant and 
postpartum women (herein after referred to as the Source Study). Participants 
were recruited from two prenatal clinics affiliated with a large university practice 
in the southeastern United States. Institutional Review Board approval was 
obtained at both the university and clinical sites and informed consent was 
received prior to the collection of data. 
 During the four year Source Study, 631 women were enrolled. Although 
the postpartum period was the actual focus of the Source Study, a single 
collection of demographic information, two psychological surveys, and blood 
were collected during the prenatal time of enrollment between 16 and 26 weeks 
gestation. This prenatal data is the focus of the current study. 
 Initially, blood collected during the prenatal stage was analyzed for a panel 
of 14 cytokines.  Due to budget restrictions, the Source Study later eliminated the 
prenatal analysis of cytokines from their study.  Therefore, prenatal cytokine data 
on only 159 participants were available for inclusion in this study. 
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Sampling Method 
 Sample size estimate. The estimated sample size for the secondary 
analysis was based on the use of multiple regression analyses as stated in aim 
two. As this aim is largely exploratory, a standard rule-of-thumb, N ≥ 104 + m 
(where m is the number of predictors), was used initially and suggested that 125 
participants was sufficient (Tabachnick & Fidell, 2007). A more precise sample 
size estimate was calculated assuming a modest value of R2 = .06, α = .05 and β 
= .20. This second estimate indicated that a sample of 122 participants would be 
sufficient to assess the study aims.  
Inclusion criteria. Healthy pregnant women were enrolled in the Source 
Study at their prenatal appointment between 16 and 26 weeks gestation. English 
and Spanish speaking participants were considered eligible for inclusion if they 
were less than 26 weeks pregnant and did not have any of the criteria for 
exclusion.   
Exclusion criteria. Criteria for exclusion included: age less than 18 and 
greater than 45 years; a body mass index (BMI) less than 20 at time of 
venipuncture; problems with drugs or alcohol or the use of drugs at any time 
during the current pregnancy; current use of immunosuppressant, hormonal or 
anticoagulant medications; personal history of thyroid or any autoimmune 
disease; serious mental illness; chronic disease; use of in-vitro fertilization for the 
current pregnancy; multiple gestation in the current pregnancy; hyperemesis; 
anemia; and known genetic abnormalities in the developing fetus. Additionally, 
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women who indicated that they could not participate in the Source Study’s six 
month postpartum follow-up were not eligible for enrollment.   
Measures 
 Demographic form. A brief demographic survey was administered to 
each participant at the prenatal time of enrollment to capture information about 
age, race, ethnicity, education, income, marital status, employment status, and 
pregnancy history. Smoking status prior to and during pregnancy was also noted. 
Recorded measures of height, pre-pregnancy weight, and weight at the time of 
blood collection were used to calculate body mass index (BMI). The BMI values 
were calculated by the Source Study and included in the data file received for the 
secondary analysis.  
 Following delivery of the baby, the Research Coordinator of the Source 
Study updated the Demographic Form. Information about the labor and delivery 
including the presence of any complications was noted. See Appendix A for a 
copy of the demographic form. 
 The Perceived Stress Scale. Self-reported levels of maternal stress were 
measured using The Perceived Stress Scale (PSS) (Cohen, et al., 1983). The 
14-item version of the scale measures how often the individual felt or thought a 
certain way with Likert-type responses ranging from 0 (never) to 4 (very often). It 
is a measure of the degree to which an individual perceives their life as stressful. 
 Developed for use with individuals with at least a junior high school 
education, the scale items are of a general focus and applicable to all sub-
populations of use. Internal consistency reliability testing in a population of 
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college-age students was found to have a coefficient alpha of .84 to .86. 
Congruent and criterion validity for the scale has been shown to be excellent, 
although predictive validity falls with time (Cohen, et al., 1983).  
 The Perceived Stress Scale is not a diagnostic instrument and therefore 
there are no established cut-off values for stress measurement.  The scale does 
not require permission for utilization when used for academic research purposes.  
See Appendix B for a copy of the Perceived Stress Scale. 
 Profile of Mood States. The Profile of Mood States (POMS) (McNair, 
Lorr, & Droppleman, 1992) was also completed by each participant at the time of 
prenatal enrollment. The tool provides for a multi-dimensional assessment of 
mood. A 65-item adjective rating scale measuring how often a feeling was 
experienced in the past week including the day of measurement, the POMS has 
a total mood disturbance score and six subscales: tension-anxiety, depression-
dejection, anger-hostility, vigor-activity, fatigue-inertia, and confusion-
bewilderment. Responses range from 0 (not at all) to 4 (extremely). The validity 
of the scale (face validity, factorial validity, predictive validity, and construct 
validity) is reported to be excellent (McNair, et al., 1992).  
 Only the depression-dejection scale (POMS-D), the sum of 15 related 
items on the total scale, was used in this analysis. The POMS-D has an internal 
consistency reliability of .84 and .95 in an antepartum population (Heaman, 
1992). The POMS-D score may range between zero and 60 however a cut-off for 
depression has not been established.  See Appendix C for a copy of the POMS. 
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 In the Source Study, the researchers established a POMS-D score of 20 
as their cut-off value for screening for severe depressive symptoms. The primary 
obstetrician or midwife providing care for women with a value of 21 or greater 
received written and verbal communication that their patient scored a 21 or 
greater on the POMS-D subscale.  Further care and/or referral was at the 
discretion of the healthcare provider.   
 Cortisol and cytokine measures. Plasma cortisol levels (µg/dl) were 
evaluated as a measure of HPA activation and stress. Cortisol was measured 
with ELISA assay kits from ALPCO Immunoassays (Salem, NH) and Calbiotech 
(Spring Valley, CA) per kit instructions. A total of four ELISA plates were 
completed in total. The first three plates of samples were completed with ALPCO 
kits from the same lot.  A fourth plate was originally completed with an ALPCO kit 
from a different lot, but results were found not to be congruent (greatly increased) 
with the earlier samples.  The fourth plate was completed again with the 
Calbiotech kit which yielded results similar to the first three plates thus a decision 
was made to include the Calbiotech results.   
 A multiplex panel of cytokines was used in this study as a measure of 
immune system activation. The cytokines chosen for this multiplex by the Source 
Study are signature pro-inflammatory and anti-inflammatory cytokines, as well as 
chemokines of importance to immune responses. Cytokines (pg/ml) measured 
were granulocyte-macrophage colony-stimulating factor (GM-CSF), monocyte 
chemotactic protein (MCP)-1, tumor necrosis factor (TNF)-α, Interferon (IFN)-γ, 
Interleukin (IL)-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12, and IL-13. A 
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bead-based assay was completed with Milliplex Map kits (Billerica, MA), and 
analyzed on a Luminex-200.  Standards and controls were completed with the 
samples for each plate used to measure cytokines and cortisol. All analyses were 
done in duplicate on each plate. Intraassay coefficients of variation for all 
laboratory measures were assessed with an acceptable variation goal of less 
than 10 percent.  
Procedures 
 Institutional Review Board Approval. Information for the current study 
was submitted for review to the Institutional Review Board (IRB).  Since a de-
identified data set would be obtained for a secondary analysis, it was determined 
by the IRB that “the described research activities do not meet the definition of 
USF HRPP Policy for Human Subjects Research” and there was no need for 
“IRB review for this Not Human Subjects Research Activities.” After review from 
the IRB, a request for Demographic, Psychological, and Physiological data on 
the 159 participants with cytokine data was made to the Principal Investigator 
(PI) of the Source Study and the data were provided in Excel format. 
 Informed Consent and Collection of Psychological Data. Institutional 
Review Board (IRB) approval was obtained at both the university and clinical 
sites for the Source Study and consent was received from each participant prior 
to the collection of data in the prenatal clinic.  Additional consent was not 
required to complete the secondary analysis.   
 Eligible participants interested in participating in the Source Study were 
provided with the consent document to read and review. After reading the 
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document, discussing the information, and allowing time for questions with the 
study recruiter, patients were provided with an opportunity to sign the consent 
document or take the document home for further review (and signature at a 
future appointment). If consent was provided, and the woman was at least 16 
weeks pregnant, then blood, psychological, and demographic data were 
concurrently collected in the clinic setting at the patient’s regularly scheduled 
prenatal appointment. If the woman was not yet 16 weeks at the time of consent, 
then the participant was met at a future clinic appointment after 16 weeks 
gestation for data collection. 
 Collection of Physiological Data. Blood was collected in three 5 milliliter 
heparinized tubes (green top) and transported to the lab in a chilled cooler. Upon 
receipt in the lab, plasma was collected by first placing tubes in the centrifuge at 
3800rpm at 0°C for 25 minutes. The plasma was aliquote d into Eppendorf tubes 
and stored in a -80°C freezer until the batched compl etion of cytokine and 
cortisol analyses. 
 Cortisol Analysis. Calibrators (standards) and controls were run for every 
plate and all analyses were completed in duplicate. On the day the assay for the 
first three plates was completed, all kit (ALPCO) reagents and samples were 
allowed to reach room temperature and placed on a vortex to mix tube contents 
prior to initiation of the procedures. Cortisol-horseradish peroxidase (HRP) 
conjugate (120 microliters) was mixed with 12 milliliters of assay buffer to 
prepare a conjugate working solution.  A wash buffer dilution was also prepared 
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by adding 50 milliliters of wash buffer concentrate to 450 milliliters of deionized 
water. 
 A pipette was used to transfer 20 microliters of each calibrator (seven in 
total), control, and sample into duplicate wells.  A multichannel pipette was then 
used to transfer 100 microliters of conjugate working solution into each well.  The 
plate was sealed and incubated on a plate shaker at 200 rpm for 45 minutes at 
room temperature. 
 Following incubation, a plate washer was used to wash the wells three 
times with diluted wash buffer.  After the final wash, the plate was gently tapped 
against absorbent paper to ensure dryness. The lights in the laboratory were 
dimmed and a multichannel pipette was used to add 150 microliters of TMB 
solution to each well. The plate was sealed, covered with aluminum foil and 
incubated on a plate shaker. After a15 minute incubation at room temperature, 
the foil was removed and a multichannel pipette was used to add 50 microliters 
of stop solution to each well. The plate was immediately read on a microwell 
plate reader at 450nm. Duplicate data were entered into GraphPad Prism 3.03 
(San Diego, CA) and analyzed for final results. 
 For the final plate, all kit (Calbiotech) reagents and samples were allowed 
to reach room temperature and placed on a vortex to mix tube contents prior to 
initiation of the procedures. Cortisol-enzyme conjugate (1milliliter) was mixed 
with 20 milliliters of assay diluents buffer to prepare a conjugate solution. A wash 
buffer dilution was prepared by adding 25 milliliters of wash buffer to 475 
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milliliters of deionized water. The laboratory lights were dimmed during the entire 
assay process. 
 A pipette was used to transfer 25 microliters of each cortisol standard 
(seven in total), high and low controls, and patient samples into duplicate wells.  
A multichannel pipette was then used to transfer 200 microliters of cortisol-
enzyme conjugate solution into each well.  The plate was sealed and mixed 
thoroughly for 10 seconds and incubated in a drawer at room temperature for 60 
minutes. 
 Following incubation, a plate washer was used to remove all liquid from 
the wells and then wash three times with diluted wash buffer.  After the final 
wash, the plate was gently tapped against absorbent paper to ensure dryness. A 
multichannel pipette was used to add 100 microliters of TMB substrate to each 
well. The plate was sealed and placed in a drawer at room temperature to 
incubate for 15 minutes. A multichannel pipette was used to add 50 microliters of 
stop solution to all wells. The plate was immediately read on a microwell plate 
reader at 450nm. Duplicate data were entered into GraphPad Prism 3.03 (San 
Diego, CA) and analyzed for final results. 
 Cytokine Analysis. On the day the immunoassay was completed, all kit 
reagents and samples were allowed to reach room temperature prior to initiation 
of the protocol. The 10x wash buffer (30 milliliters) was diluted with 270 milliliters 
of deionized water.  Quality controls were reconstituted with 250 milliliters of 
deionized water, inverted several times and placed on a vortex to mix. Controls 
were allowed to sit for 10 minutes and then were placed in labeled 
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microcentrifuge tubes. A serum matrix reconstitution was prepared by mixing one 
milliliter of deionized water with lyophilized serum matrix. Finally, human cytokine 
standards were prepared by reconstituting the human cytokine standard with 250 
milliliters deionized water to prepare a 10,000 pg/ml concentrate and serial 
dilutions completed to result in standard concentrations of 2,000 pg/ml, 400 
pg/ml, 80 pg/ml, 16 pg/ml, and 3.2 pg/ml.  During some of the analyses, an 
additional dilution was completed to achieve a concentration of 1.6 pg/ml. 
 Assay buffer (200 microliters) was added to each well of the filter plate.  
The plate was sealed and mixed on a plate shaker for 10 minutes at room 
temperature. A vacuum was used to remove the assay buffer and excess buffer 
was blotted from the bottom of the plate on absorbent paper. Twenty-five 
microliters of each standard and control was added to appropriate wells and 25 
microliters of assay buffer was added to the sample wells. Twenty-five microliters 
of the prepared serum matrix was added to the standards and control wells and 
25 microliters of each sample were added to the appropriate wells. 
 The kit bead bottle was placed on a vortex to mix and then 25 microliters 
of the beads were added to each well.  The plate was sealed, covered with a 
plate cover, wrapped with a rubber band and incubated overnight at 4°C on a 
plate shaker. Following the overnight incubation, the fluid was removed with a 
vacuum and the plate was washed two times with a plate washer and excess 
fluid blotted on an absorbent towel.  
 Detection antibodies (25 microliters) were added to each well and the 
plate was sealed, covered with the plate cover, and incubated on a plate shaker 
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at room temperature for one hour. Streptavidin-Phycoerythrin (25 microliters) was 
added to each well and the plate was sealed, covered with a plate cover and 
incubated for an additional 30 minutes on a plate shaker at room temperature. All 
well contents were then removed with a vacuum and the plate was washed two 
times with a plate washer. Sheath fluid (150 microliters) was added to all wells 
and a plate shaker was used to resuspend the beads prior to running the plate on 
the Luminex-200. Median fluorescence intensity was converted into picograms 
per milliliters.  
 Storage of study materials. Study forms were stored at the university 
where the Source Study was conducted.  Forms are locked in a filing cabinet 
draw accessible only to the PI and study personnel. Files will be maintained for 
three years following completion of the final report of the Source Study. Original 
data forms were not accessed for the purposes of the secondary analysis. 
Electronic data files from the current study were password protected when 
possible (i.e. Excel files) and do not contain personal identifiers of the 
participants.   
Data Analysis 
 Only participants with complete data on the key variables of interest were 
included in the analysis.  Patient characteristics of interest included age, 
ethnicity, race, and gravidity (number of times pregnant). Perceived stress and 
depressive symptoms were key psychological variables.  Physiological variables 
under study were cortisol (a stress hormone and marker of HPA activation) and 
inflammatory cytokines (markers of immune status).  
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 Since the collection of data occurred between 16 and 26 weeks, it was 
important to note the exact gestational age at the time of data collection to 
determine if the variation among collection times had any effect on the outcomes.  
This was especially important in relation to the physiological variables whose 
levels are known to fluctuate throughout pregnancy.  Finally, since gestational 
age at the time of delivery is the main outcome variable, information about the 
estimated date of delivery and the actual date of delivery were required so 
gestational age could be calculated.   
 Preliminary Analyses. Prior to analysis, data were reviewed for accuracy 
of data entry, missing values, and outliers. Statistical analyses were conducted 
using SPSS statistical software (IBM SPSS Statistics 19).   
 Gestational age at delivery was calculated by first subtracting the actual 
date of delivery from the estimated date of delivery identified in the patient’s 
prenatal record and recorded in the Source Study data file.  In relation to the 
estimated date of delivery, positive values identified the number of days the 
pregnancy was shortened and negative values were the result in longer 
pregnancies.  These positive and negative values were then subtracted from 280 
days (i.e. the number of days equal to a full term pregnancy of 40 weeks) to 
determine the gestational age at delivery.   
 The gestational age at the time that the data were collected was 
calculated in the same manner.  The date that the blood was collected was 
subtracted from the estimated date of delivery.  That value was then subtracted 
from 280. 
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 As previously mentioned, serial dilutions were completed resulting in the 
lowest standard concentration of 3.2 pg/ml or 1.6 pg/ml. These values were 
considered to be the lowest limit of detection (LOD) for each laboratory plate. 
Using conventional methods, cytokine values indicated by Luminex output to be 
lower than the LOD were replaced with a value that was one-half the lowest limit 
of detection. Therefore, one-half of the LOD was either 1.6 pg/ml (i.e. one-half of 
3.2) or .8 pg/ml (i.e. one-half of 1.6) depending upon which dilution method was 
utilized.   
 After reviewing the cytokine data, it was noted that some samples had 
been assayed on two separate occasions. Data from both assays were available 
in the Excel data file obtained from the Source Study. If two measurements were 
available, then they were averaged to obtain a single value which was utilized for 
analysis.  
 Cytokine and cortisol data were first evaluated for extreme outliers that 
were more than three standard deviations from the mean.  Cases greater or less 
than three standard deviations on any of the variables were excluded from the 
analysis.  Next, the cytokine and cortisol data were evaluated for skewness by 
calculating the skewness measure and visualizing a histogram using SPSS.  
Log10 transformation of physiological variables was used to reduce skewness 
and normalize the distribution (Tabachnick & Fidell, 2007).  Following 
transformation, a ratio of IL2 to IL4 was calculated to determine the Th1/Th2 
state of each individual at the prenatal time of data collection. 
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 Individual item responses on the Perceived Stress Scale were made 
available in the Excel data file received from the Source Study.  Item responses 
were used to calculate the total score on the Perceived Stress Scale per author 
instructions.  Since the data received were on a scale of 1 to 5 instead of 0 to 4, 
the responses were first recoded to agree with the original scale measurement. 
The scores on the seven positive items were reversed (0=4, 1=3, 2=2, 3=1, and 
4=0) and then all 14 items were summed to calculate a total score (Cohen, et al., 
1983). The Cronbach’s alpha for the current sample was .77 for the 14-item 
scale. 
 The POMS-D subscale score is the sum of the 15 related items from the 
total POMS scale responses (McNair, et al., 1992).  Individual scores on the 
scale’s 65 items were not available in the data set received from the Source 
Study.  The subscale scores were calculated by the Source Study personnel and 
only the six subscale scores and the total mood disturbance score were identified 
in the received data set.  
 Review of the POMS-D data revealed that the data were positively 
skewed.  A square root transformation method was utilized to achieve a normal 
distribution. Reliability estimates for the current sample were not able to be 
calculated since only subscale scores were provided and individual item scores 
were not available. 
 Descriptive statistics were calculated to summarize the participant 
characteristic information, total PSS score, and POMS-D subscale.  Mean scores 
and standard deviations (SD) were calculated for the PSS, POMS-D, cortisol and 
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individual cytokines.  Untransformed raw data were used to calculate and report 
the descriptive results.  All comparative analyses were conducted using 
transformed data. 
 Analyses to Address the Aims. To address the aims, the following data 
analysis methods were executed: 
 Aim 1. Estimate the bivariate relationship between mid-pregnancy 
measures of physiological and psychological variables and gestational age at 
delivery. 
 Bivariate methods were utilized to explore the association between the 
variables of interest.  The Pearson correlation coefficient (r) was calculated to 
estimate the relationship between the variables of interest and gestational age at 
delivery.  Correlations measure the size and direction of the linear relationship 
between two variables. Also, the squared correlation yields the measure of 
strength of association between the variables (Tabachnick & Fidell, 2007). 
 Values for the correlation coefficient always lie between +1 and -1.  If all 
values lie on a straight line with a negative slope, then r would equal -1 and a 
straight line with a positive slope equals +1. A value of zero is interpreted as the 
absence of a linear relationship between the variables (Dunn & Clark, 2009). If r 
is less than zero, then the dependent variable decreases as the independent 
variable increases and vice versa.  If r is greater than zero, then as the 
independent variable increases (or decreases), then so does the dependent 
variable (Wilcox, 2009). 
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 Scatter plots were created to graphically depict the linear relationship 
between the variables. Gestational age at delivery represented the dependent 
(Y) variable and the psychological and physiological variables were the predictor 
(X) variables. Significant correlations were identified as calculated using SPSS 
statistical methods. 
 It was considered to be important to remove the influence of medically 
indicated deliveries on gestational age at delivery. Therefore, if necessary, we 
planned to calculate semipartial correlation coefficients to estimate the 
relationship between each physiological and psychological variable and 
gestational age at delivery after controlling for the medically indicated deliveries. 
However, since a linear relationship between medically indicated deliveries and 
gestational age at delivery was not found to exist (using Pearson’s r), this method 
was not implemented. 
 Aim 2. Examine the unique role played by physiological and psychological 
variables in predicting gestational age at delivery in a multivariate model. 
 Multiple linear regression techniques were utilized to examine the unique 
role of physiological and psychological variables with gestational age at delivery. 
A forward regression analysis was used with a liberal probability level of entry set 
at .20. The squared semi-partial correlations estimate the amount of variance 
that each independent variable adds to R2 at the point that it enters the 
regression equation (Tabachnick & Fidell, 2007). The contribution of an 
independent variable to the prediction of the dependent variable depends upon 
the point of entry into the equation that is automatically selected by SPSS. 
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 Starting with only the constant, each potential predictor variable is entered 
until the best model is achieved. Irrelevant variables are rejected from the model. 
Order was based on the partial correlations using the FORWARD method in 
SPSS.  Predictors were added to the model one-at-a-time until there was no 
improvement in fit. 
 To enhance the predictive relationship of the independent variables on the 
dependent variable, several assumptions must be met.  First, a linear relationship 
must exist between the predictors and the outcome.  Linearity was assessed by 
review of scatterplots described in Aim 1 above. Second, a normal distribution of 
variables must exist.  Assessment of normality was also conducted by review of 
scatterplots and consideration of skewness and outliers. Linearity and distribution 
of the physiological variables was improved by employing Log10 transformation 
methods. Homogeneity of variance is also assumed whereby the variance of 
scores of one variable is approximately that of the other variables. The final 
assumption is the absence of multicollinearity. Multicollinearity exists when 
independent (predictor) variables are too highly correlated (Logan, 2010). 
Multicollinearity was evaluated using SPSS collinearity diagnostics.  Criteria 
included a conditioning index greater than 30 for a given dimension coupled with 
variance proportions greater than .50 for at least two different variables 
(Tabachnick & Fidell, 2007). Among the current set of variables, condition indices 
were not found to be greater than 12 therefore multicollinearity was not found to 
be present. 
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Chapter Summary 
 This chapter summarized the methods implemented in the current 
research.  This study was a secondary analysis of data obtained during 
pregnancy from women participating in a larger study of stress, immunity, and 
thyroid disease in the postpartum period. The relationship of participant 
characteristics, psychological variables (perceived stress and depressive 
symptoms), and physiological variables (cortisol and cytokines) to gestational 
age at the time of delivery was investigated.   
 Chapter four contains the results of Pearson’s Correlations and Forward 
Regression.  Additionally, sample characteristics have also been summarized in 
the following chapter. 
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CHAPTER FOUR 
RESULTS 
 
Preliminary Analyses 
 Missing data, normality and outliers. A total of 25 cases were not 
included in the analysis due to incomplete data on key variables or failing to meet 
inclusion criteria.  Twelve cases were missing some or all of the psychological 
data. One case was missing cortisol results and another was missing values for 
seven of the 14 cytokines.  Other cases excluded from the analyses included 10 
individuals for which delivery information was not available and one person who 
delivered twins instead of a singleton birth. An additional 12 cases were lost after 
excluding individuals with extreme outliers.  The final sample was 122 
participants who were included in all of the descriptive and comparative 
analyses. 
 Valid data on only 12 of the 14 cytokines were available for all 
participants.  Eighteen (14.8%) and two (1.6%) participants were missing data for 
GM-CSF and MCP-1, respectively.  Instead of further eliminating cases and risk 
affecting statistical power and increase chances of making a Type I or Type II 
error, these two cytokines were not included in the final analyses. 
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 The remaining 12 cytokines and cortisol results were assessed for 
skewness. All were found to be positively skewed (cases were piled on the left of 
the distribution with a long right tail) with skewness values all greater than zero. 
The Log10 transformation was the method utilized to correct the skewness and 
achieve a normal distribution.   
 Participant age, gestational age at the time of enrollment, and gestational 
age at delivery were also assessed for normal distribution.  Gestational age at 
the time of delivery was found to be negatively skewed and was corrected using 
Log10 transformation with reflection. The remaining two variables did not require 
correction. 
 Description of the sample. Participants ranged in age from 18 to 43 
years (M = 27.39; SD = 5.44). The most frequent race reported was Caucasian 
(n = 84; 68.9%), while 23.0% identified themselves as African-American/Black (n 
= 28), 4.9% as ‘Other’ (n = 6), and 3.3% as Asian/Pacific Islander (n = 4). The 
ethnicity of the sample was primarily Non-Hispanic (n = 90; 73.8%). 
 Previous pregnancy history (including the current pregnancy) reported by 
women ranged in number from one (n = 34; 27.9%) to nine (n = 1; <1.0%). Most 
women (n = 49; 40.2%) had no living children at home, 43 women (35.2%) 
currently had one child in the home, and 21 women (17.2%) had two children. 
For one woman (1.0%), the current pregnancy would add to her seventh child to 
her home. 
 Of the babies born to this sample, 59 were male (48.4%) and 60 were 
female (49.2%).  The gender of three babies (2.5%) was not identified in the data 
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file from the Source Study. The majority of babies were delivered vaginally (n = 
86; 70.5%) and most women entered into labor spontaneously (n = 84; 68.9%). 
The pregnancy history was reviewed for diagnosis of preterm labor, gestational 
hypertension, or gestational diabetes.  Twenty-seven women (22.1%) 
experienced one or more of those conditions during the current pregnancy.  
 The study protocol defined the eligibility period for prenatal enrollment and 
data collection from 16 weeks to 26 weeks gestation.  The actual gestational age 
at the time of enrollment ranged from 97 days (13 weeks and 6 days) to 182 days 
(26 weeks) with a mean gestational age of 140 days (20 weeks). Gestational age 
at the time of delivery ranged from 154 days (22 weeks) to 291 days (41 weeks 
and 4 days).  The mean gestational age at the time of delivery was 269.95 days 
(38 weeks and 3 days).  
 Psychological and physiological variables. The mean score on The 
Perceived Stress Scale was 23.40 (SD = 6.59) with a range in scores from 6 to 
45.  Scores on the Profile of Mood States Depression subscale ranged from 0 to 
42 (M = 6.65; SD = 8.87). Eleven women had depressive symptom scores of 21 
or greater. These scores were reported to their physician or midwife for further 
treatment or referral.  
 Table 3 summarizes the physiological variables in the study.  The 
untransformed raw data were used to calculate this descriptive information. As 
mentioned previously, data were not available for all participants for GM-CSF 
and MCP-1 and were excluded from comparative analyses. Of the remaining 12 
cytokines and cortisol, four were undetectable in more than half of the plasma 
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samples. These undetectable cases were assigned a value prior to Log10 
transformation that was one-half the limit of detection (either .80 or 1.6) as 
described in Chapter 3. 
 
TABLE 3. Summary of physiological results 
Cytokine Mean (SD) Min/Max # Below LOD* 
TNF-alpha 3.55 pg/ml (3.06) 1.20/ 24.20 pg/ml 13 (10.66%) 
IFN-gamma 1.76 pg/ml (2.29) .22/ 21.36 pg/ml 90 (73.77%) 
IL-1beta 2.04 pg/ml (1.99) .40/ 12.84 pg/ml 75 (61.48%) 
IL-2 4.02 pg/ml (6.27) .40/ 55.22 pg/ml 53 (43.44%) 
IL-4  23.45 pg/ml (55.11) .99/ 398.62 pg/ml 45 (36.89%) 
IL-5 1.49 pg/ml (.77) .40/ 5.79 pg/ml 96 (78.69%) 
IL-6 4.12 pg/ml (6.67) .93/ 49.91 pg/ml 45 (36.89%) 
IL-7 15.03 pg/ml (31.10) 1.06/ 166.21 pg/ml 56 (45.90%) 
IL-8 11.85 pg/ml (19.78) 1.20/ 166.87 pg/ml 5 (4.10%) 
IL-10 5.42 pg/ml (7.92) .80/ 37.45 pg/ml 42 (34.43%) 
IL-12 6.88 pg/ml (15.55) .23/ 98.27 pg/ml 60 (49.18%) 
IL-13 2.93 pg/ml (4.75) 1.18/ 37.95 pg/ml 78 (63.93%) 
Cortisol 15.66 µg/dl (6.97) 6.12/ 43.54 µg/dl  0 (0 %) 
*LOD = Limit of Detection 
 
Analyses Addressing the Study Aims 
 Aim 1. Estimate the bivariate relationship between mid-pregnancy 
measures of physiological and psychological variables and gestational age at 
delivery. 
  Research Question 1. To what extent are mid-pregnancy maternal 
plasma cytokines correlated with gestational age at delivery? Two of the 12 
cytokines included in the correlation analysis were significantly correlated with 
gestational age at delivery. Both were negatively correlated indicating that as 
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gestational age increased, cytokine levels decreased.  Interferon gamma had the 
strongest correlation (r = -.22) with gestational age at delivery.  
  Research Question 2. To what extent are mid-pregnancy maternal 
plasma cortisol levels correlated with gestational age at delivery? Plasma cortisol 
was not significantly correlated with gestational age at delivery (r = .06, p = .53).  
As discussed in the review of the literature, cortisol levels increase as gestational 
age increases and until delivery.   
  Research Question 3. To what extent are mid-pregnancy perceived 
stress scores correlated with gestational age at delivery? Self-reported levels of 
perceived stress were not significantly correlated with gestational age at delivery 
(r = -.07, p = .44).  
  Research Question 4. To what extent are mid-pregnancy 
depressive symptoms scores correlated with gestational age at delivery? Self-
reported levels of depressive symptoms were also not significantly correlated 
with gestational age (r = .07, p = .44). 
 Table 4 identifies the Pearson’s r values between all variables in the 
current study.  Of the independent variables of interest, only 2 cytokines (IL13 
and IFNγ) and gravida (r = .28, p = .002) resulted in significant correlations with 
the dependent variable.  
    Aim 2. Examine the unique role played by physiological and psychological 
variables in predicting gestational age at delivery in a multivariate multiple 
regression model. 
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TABLE 4. Correlations of key variables 
   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21    22 
 1 GA (days)^ 1.00 0.14 0.13 0.12 -0.08 0.28* 0.15 -0.07 0.06 -0.14 -0.12 -0.10 0.03 -0.11 -0.13 0.04 -0.08 -0.11 -0.18* -0.22* -0.11 0.10 
 2 Enroll (days)#  1.00 -0.02 -0.05 -0.05 0.02 -0.09 -0.06 0.37† -0.05 -0.03 0.09 -0.09 -0.03 -0.05 -0.07 0.05 0.00 -0.02 -0.01 -0.08 -0.07 
 3 Age   1.00 -0.02 0.01 0.36† 0.06 -0.09 -0.09 0.00 0.00 0.12 0.06 0.08 0.13 0.11 0.18* 0.03 -0.06 -0.11 -0.05 0.09 
 4 Race    1.00 -0.10 -0.06 0.02 0.00 0.11 -0.08 -0.08 0.02 -0.08 0.11 0.03 -0.06 0.08 0.03 -0.05 -0.01 -0.04 0.00 
 5 Ethnicity     1.00 0.07 0.17 0.00 0.08 -0.13 -0.19* -0.10 -0.02 -0.04 -0.09 0.08 -0.14 -0.02 -0.02 -0.07 -0.15 -0.01 
 6 Gravida      1.00 0.36† 0.21* 0.04 -0.04 0.05 -0.07 -0.02 0.00 -0.04 0.10 -0.03 0.07 0.00 0.00 -0.10 0.17 
 7 POMS-D       1.00 0.64† 0.05 -0.08 -0.14 -0.10 -0.05 -0.13 -0.16 -0.01 -0.18* -0.13 -0.11 -0.08 -0.26* 0.03 
 8 PSS        1.00 0.05 -0.03 -0.04 -0.10 -0.12 -0.01 -0.11 -0.05 -0.09 -0.16 0.05 -0.07 -0.15 0.06 
 9 Cortisol         1.00 -0.14 0.06 -0.25* -0.20* -0.01 -0.10 -0.07 -0.10 -0.11 -0.10 0.00 -0.06 0.18* 
10 IL1β          1.00 0.49† 0.38† 0.60† 0.43† 0.41† 0.09 0.38† 0.29† 0.49† 0.43† 0.00 -0.06 
11 IL2           1.00 0.06 0.22* 0.52† 0.23* 0.00 0.16 0.29† 0.46† 0.35† 0.05 0.53† 
12 IL4            1.00 0.30† 0.29† 0.73† 0.41† 0.73† 0.37† 0.40† 0.15 0.13 -0.39† 
13 IL5             1.00 0.13 0.37† 0.08 0.31† 0.46† 0.35† 0.39† -0.04 -0.16 
14 IL6              1.00 0.37† 0.28* 0.47† 0.40† 0.63† 0.32† 0.16 0.16 
15 IL7               1.00 0.36† 0.68† 0.29† 0.40† 0.18* 0.22* -0.21* 
16 IL8                1.00 0.36† 0.25* 0.26* 0.09 0.36† -0.16 
17 IL10                 1.00 0.24* 0.51† 0.16 0.22* -0.24* 
18 IL12                  1.00 0.40† 0.55† 0.01 -0.06 
19 IL13                   1.00 0.43† 0.24* -0.11 
20 IFNγ                    1.00 0.07 -0.13 
21 TNFα                     1.00 -0.14 
22 Th1/Th2                      1.00 
^Gestational age at delivery, #Gestational age at enrollment, *p ≤ .05  †p ≤ .001 
 
 
 
69 
 
 The data were reviewed to assess if the assumptions of regression had 
been met.  The linear relationship between the physiological predictors and 
outcome was confirmed by review of the scatterplots in Figures 5 through 17 (at 
end of chapter). Log10 transformation was used to correct skewness of the 
variables to achieve a normal distribution.  Although some variables were 
correlated with one another, multicollinearity was not found to be present. 
 Forward (Stepwise) regression was then employed to examine the unique 
role of the cytokines with gestational age at delivery. Three models were 
identified with multiple correlations coefficients (R) ranging from .22 to .29. The 
third model included the variables IFNγ (β = -.26, p = .01), IL5 (β = .19, p = .07), 
and IL7 (β = -.16, p = .10). The combination of these three variables significantly 
explained a proportion of the variance of gestational age at delivery (R2 = .06, F = 
3.61, p = .02). Six percent of the variability of the dependent variable (gestational 
age at delivery) can be explained by the variability of the combination of these 
three cytokines in the model.  
Additional Testing 
 The variables of interest were further described based on the point at 
which the prenatal samples were collected.  The sample was first divided into two 
groups since levels of cytokines and cortisol fluctuate and often increase during 
pregnancy and there was a wide variation in the gestational age at which the 
data were collected (between 16 and 26 weeks).  Group one (n = 58) included all 
of the data that were collected between 16 and 20 weeks gestation.  Group two 
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(n = 64) was made up of women who enrolled between 20 and 26 weeks 
gestation. 
 Results of ANOVA showed that gestational age at enrollment had a 
significant effect on cortisol (F(1, 121) = 12.47, η2 = .09, p = .001) and IL7 levels 
(F(1, 121) = 3.962, η2 = .03, p = .05). Mean cortisol levels of women in group one 
were 13.42µg/dl (SD = 5.65) and group two was 17.69µg/dl (SD = 7.46). For 
women enrolled between 16 and 20 weeks, the average IL7 levels were 
20.85pg/ml (SD = 41.40).  Mean IL7 levels were 9.76pg/ml (SD = 15.75) for 
those enrolled between 20 to 26 weeks gestation. The gestational age at 
enrollment did not significantly effect on any of the remaining psychological or 
physiological variables in the study. 
 The Th1/Th2 ratio was also calculated.  This ratio is an indicator of 
whether the individual’s immune system favors a Th1 or Th2 state at the time 
that blood was collected.  As indicated in Chapter 3, it was calculated using one 
key cytokine from each Th state. Interleukin-2 was selected as the key indicator 
of Th1 and IL-4 for Th2. A value greater than 1.0 results when Th1 (IL-2) is 
greater and less than 1.0 when Th2 (IL-4) is greater. 
 The ratio ranged from .01 to 11.02 (M = 1.47; SD = 2.28) in the sample of 
women. Thirty-eight women favored a Th1 state with a ratio greater than 1.0 and 
64 favored a Th2 state. Twenty women actually had a ratio equal to 1.0 indicating 
a balanced Th1/Th2 state.  
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Chapter Summary 
 Chapter four included the results of the descriptive analyses, testing for 
the two study aims and additional descriptive analyses. Pearson’s correlation 
methods were carried out to examine the relationships investigated in the first 
aim.  Forward linear regression was used to explore the second aim and identify 
the best fit model to explain the relationship between the predictor variables and 
the outcome variable (gestational age at delivery). 
 Chapter five will discuss the findings presented in the current chapter.  
The chapter will interpret how these findings relate to previous research and how 
they present the foundation for future research. 
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Figure 5. Scatterplot for Gestational Age and IL1β 
 
 
 
 
Figure 6. Scatterplot for Gestational Age and IL2 
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Figure 7. Scatterplot for Gestational Age and IL4 
 
 
 
 
Figure 8. Scatterplot for Gestational Age and IL5 
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Figure 9. Scatterplot for Gestational Age and IL6 
 
 
 
 
Figure 10. Scatterplot for Gestational Age and IL7 
75 
 
 
Figure 11. Scatterplot for Gestational Age and IL8 
 
 
 
 
Figure 12. Scatterplot for Gestational Age and IL10 
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Figure 13. Scatterplot for Gestational Age and IL12 
 
 
 
 
Figure 14. Scatterplot for Gestational Age and IL13 
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Figure 15. Scatterplot for Gestational Age and IFNγ 
 
 
 
 
Figure 16. Scatterplot for Gestational Age and TNFα 
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Figure 17. Scatterplot for Gestational Age and Cortisol 
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CHAPTER FIVE 
DISCUSSION 
 
Discussion of Findings 
 Measures were carried out to examine the relationship between 
psychological and physiological variables and the outcome variable, gestational 
age at delivery.  Pearson correlations showed a significant negative linear 
relationship between IFN-γ and IL-13 with gestational age. This relationship 
indicates that women with higher levels of these cytokines have shorter 
pregnancies than do women with lower levels.   
 Interferon gamma is a key pro-inflammatory cytokine produced by Th1 
cells while IL-13 is an anti-inflammatory cytokine usually associated with a Th2-
like state. Natural Killer (NK) cells are a predominant producer of IFN-γ, and IL-
13 to a lesser extent (Fitzgerald, et al., 2001). These cytokines generally work in 
opposition so as levels of one cytokine increases, then the level of the other 
decreases.  Concurrent elevation of IFN-γ and IL-13 was an unexpected result, 
however similar findings have been reported. 
 In a study by Gargano et al. (2008), Th1 (IL-1, IL-2, IL12, IL-18, IFN-γ, 
TNF-α, and TNF-β), Th2 (IL-4, IL-6, and IL-10), and Th17 (IL-17, TGF-β, and 
GM-CSF) cytokines were investigated at mid-pregnancy to examine their 
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relationship to spontaneous preterm labor. Maternal plasma samples were 
collected between 15 to 27 weeks gestation (prior to the onset of preterm labor). 
Their findings showed concurrent elevations in levels of Th1 and Th2 cytokines in 
women who delivered prior to term (i.e. shortened gestation), although their 
findings were only in the presence of histologic chorioamnionitis. 
 In other studies of samples collected at mid-gestation, levels of IFN-γ have 
been shown to increase from the first to second trimester in normal, 
uncomplicated pregnancies carried to term (Curry, et al., 2008). Elevated levels 
of IFN-γ and IL-6 in plasma samples collected at 25 weeks gestation were shown 
to be weakly associated with an increased risk for delivering between 34 to 36 
weeks gestation, but not to a degree that would be useful in the prediction of 
preterm delivery (Curry et al., 2007). 
 Since pregnancy is characterized by a shifting state of pro-inflammation 
during the first trimester, anti-inflammation during trimesters two and three, and 
then pro-inflammation at parturition (Mor & Cardenas, 2010), comparison of 
current findings to studies conducted at a time other than mid-pregnancy is a 
challenge. The analysis of only one time-point during pregnancy limits the ability 
to assess the shifting balance of cytokines, but the current findings may be 
representative of the time of transition from the pro-inflammatory state (indicated 
by the IFN-γ levels) to the anti-inflammatory state (IL-13 levels). Additionally, 
inter-study comparison is made more difficult by the varied methods of sampling 
sources (amniotic fluid, circulation, cervical fluid, placental tissue, etc) and 
method of analyses (flow cytometry, ELISA, or Luminex). 
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 Strong correlations among cytokines (both pro-inflammatory and anti-
inflammatory) were also shown in the current study. This relationship may be due 
to the regulation of cytokines by their interaction with one another. Methods 
carried out during this study were not able to decipher the source of secretion of 
the circulating cytokines which may have originated from the maternal-fetal unit 
or another source of inflammation in the body. 
 A weak positive correlation was shown to be present between gravidity 
and pregnancy length indicating that the length of the pregnancy increased as 
the number of pregnancies increased.  However, when gestational age at 
delivery was categorized into three groups (those who delivered less than 38 
weeks, 38 to 40 weeks, and 40 weeks or greater) and analyzed with ANOVA, the 
mean gravidity was highest in those women who delivered at less than 38 weeks 
and lowest in the over 40 week group. In a previous study, women delivering 
prior to term were more likely to be multi-gravid and nulliparous (i.e. more than 
one pregnancy without a subsequent delivery) (Curry et al., 2009). Further 
analysis of the current study sample showed no differences between the 
gestational age at delivery and women who were primigravid, multi-gravid 
women who were nulliparous, and multi-gravid women who were multiparous. 
Gravidity has not been shown to have an association with maternal cytokine 
levels during pregnancy (Curry, et al., 2009; Curry, et al., 2007; Curry, et al., 
2008) although, in the current sample, IL-6 was significantly elevated in multi-
gravid/nulliparous women. 
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 The second aim was to examine the unique role played by physiological 
and psychological variables in predicting gestational age at delivery. The best 
model to predict gestational age at delivery (y) given (x), was from the combined 
variables, IFN-γ, IL-5, and IL-7. Six percent of the variability of the dependent 
variable (gestational age at delivery) can be explained by the variability of the 
combination of these three cytokines in the model.  
 Perceived stress and depression were key psychological variables of 
interest in the current study. Neither demonstrated a positive correlation with 
gestational age at delivery, nor were they identified as a good predictor in the 
regression model.  This is an unexpected finding since perceived stress has 
been previously shown to be inversely related to gestational length (Hobel, 
Dunkel-Schetter, et al., 1999; Ruiz, et al., 2002) and prenatal depression 
 has been found to be positively related to preterm delivery (Fransson, et al., 
2011; Phillips, et al., 2010; Smith, et al., 2011). The absence of a correlation may 
be due to the small number of women reporting depressive symptoms in the 
current population. There may have not been enough variation in the stress and 
depression scores to identify a relationship with gestational age.  Interesting to 
note, both depression and perceived stress had significant positive correlations 
with gravidity which was correlated with gestational age at delivery. 
 Not unexpected was the finding that the gestational age at which the blood 
sample was collected had a significant effect on the level of cortisol measured. 
Women whose blood was collected between 20 to 26 weeks had higher cortisol 
levels than those taken between 16 to 20 weeks. Pregnancy is characterized by 
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a managed state of cortisolemia and a rise in cortisol during pregnancy increases 
the production of pCRH (Sandman, et al., 2011). These levels continue to rise 
until the onset of parturition (McLean, et al., 1995; Wadhwa, et al., 1998). 
Limitations 
 This study was conceived after data collection had taken place during the 
Source Study on postpartum thyroiditis. As mentioned, the current analyses were 
limited to a single blood sample obtained during the second trimester of 
pregnancy. It was not possible to describe the individuals’ baseline status as a 
comparison for change, nor could a trend in levels of cortisol and cytokines 
during pregnancy and until delivery be estimated.  
 Also, since the time of day that blood samples were collected was not 
recorded for all patients, it was not possible to control for the diurnal variation in 
the physiological variables. Blood samples were collected at participants’ 
regularly scheduled prenatal appointments which occurred between 8:30am and 
6:00pm in those with times recorded. Differences in biological outcomes or 
relationships may be impacted based on sampling time.   
 Assessment of cytokines in this study was by analyses of systemic levels 
found in plasma.  Many cytokine measurements were below the limit of detection 
and an estimated value had to be used for the analysis.  Improvements in 
detection methods need to be identified for future studies.  Also, it was not 
possible to identify the source of cytokine secretion. Plasma cytokine levels may 
be indicative of actions occurring elsewhere in the body other than at the 
maternal-fetal interface. Although peripheral collection of venous blood can be 
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done with ease, perhaps concurrent assessment of cervical fluid throughout the 
pregnancy would provide a better assessment of the cytokine profile related to 
pregnancy.   
 Gestational age in the current study was calculated by subtracting the 
exact date of delivery from the estimated date of delivery as noted in the 
participant’s chart.  The estimated date of delivery in the chart was calculated 
based on the woman’s last menstrual period and confirmed with ultrasound. 
Even with the use of technology, the estimated date of delivery is just that - - an 
estimate.  Women usually give birth +/- seven to 10 days from their estimated 
date of delivery. This known variability should be acknowledged since women 
who appeared to have delivered pre- or post-term may have actually been closer 
to term than estimated. 
 The Profile of Mood States Depression-Dejection subscale is a measure 
of dysphoric mood and is a screening tool for clinical depression. This study 
should be repeated with a depression instrument validated in a pregnant sample. 
An instrument such as the Edinburgh Postnatal Depression Scale (Cox, Holden, 
& Sagovsky, 1987) may be a more appropriate alternative. 
Conclusions 
 Pregnancy is a dynamic state characterized by obvious changes in 
maternal characteristics, as well as alterations within the body that go unnoticed.  
A successful pregnancy to term gestation relies on the delicate balance of pro- 
and anti-inflammatory cytokines of the immune system. Alterations in this 
balance may lead to complications such as preterm labor, preeclampsia, and 
85 
 
gestational diabetes. Despite advances in medical research, the rate of early 
delivery in the United States continues to rise.  Continued research is needed to 
identify early indicators of an altered gestational length so preventive 
interventions may be developed. 
Implications for Future Research 
 A longitudinal study should be completed to accurately describe the 
shifting levels of cytokines and cortisol throughout pregnancy and postpartum 
recovery. Women should be enrolled and measurements completed beginning at 
their first prenatal appointment and monthly until delivery and six months 
postpartum. Non-pregnant controls would provide a comparison of pregnant to 
non-pregnant cytokine levels and findings may be used as a benchmark for 
future studies. 
 The current variables under study should be included in future research to 
further investigate their relationship to preterm delivery versus term delivery.  The 
study would require a larger sample size and one with fairly equal cases of term 
and preterm pregnancies. Key Th1 and Th2 cytokines should be chosen for 
analysis based on the success of detection in pilot testing, therefore only those 
analytes with successful detection in ~75% of cases tested should be 
considered. Perhaps diurnal variation of cytokine levels should be considered 
and blood collected at a time of day when concentrations are greatest and 
detection would be best. 
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Appendix A 
Demographic Form 
 
Last Name: 
 
First Name: Initial: 
   
DOB: _____/_____/_____ 
 
Due 
Date:____/____/_____ 
 
 
Pre-Pregnancy Wt:______ 
Address:   
Street:_____________________ 
City:____________ 
State:_______ 
Zip Code: ____________  
 
Ht: _______     BMI:_______ 
Phone Number: 
____________________ 
Home:__________________ 
Cell: 
________________________ 
Emergency Contact 
Name:_______________ 
Phone 
Number:_______________ 
Email:___________________ 
 
Demographic Information   
Race/Ethnicity: 
o Caucasian 
o African-American 
o Asian/Pacific Islander 
o Native American 
o Hispanic Origin   
○ White    ○ Black 
o Other 
 
Education: 
o Grammar 
School 
o Middle School 
o High School 
Graduate 
o College 
Graduate 
o Post Graduate 
o Type of 
work________ 
 
Household Income (Yearly): 
o Under $4,999 
o $5,000-14,999 
o $15,000-24,999 
o $25,000-39,999 
o $40,000-69,999 
o $70,000+ 
Marital Status: 
o Single 
o Married 
o Divorced 
o Widowed 
Current Working 
Status: 
o Part time 
o Full time 
o Not at all 
Hours/week: 
______ 
Number of 
Pregnancies: 
 
___ Total pregnancies 
___ Full Term 
___ Premature 
___ AB, induced 
___ AB, Spontaneous 
___ Ectopics 
___ Multiple Births 
___ Living 
 
 
 
 
 
How many 
children do 
you have? 
________ 
Number 
living in 
household: 
 
_________ 
Medical History 
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Do you Smoke? 
o Yes 
o No 
If Yes,  how many 
cigarettes/day: 
______ 
Did you smoke 
during your 
pregnancy? 
o Yes 
o No 
If Yes, how many 
cigarettes/day: 
____ 
Are you currently 
exercising? 
o None 
o 0-30 min. per week 
o 30-60 min. per week 
o 60-90 min. per week 
o 90-120 min. per 
week 
o 120+ min per week 
Type of Exercise: 
o Very Strenuous 
(Jogging) 
o Pretty Strenuous 
(Walking up a hill) 
o Mildly Strenuous 
(Walking your pet) 
o Not Strenuous (Light 
housework) 
 
Are you currently receiving any medical treatment for any 
health problems? If so please list. 
o No 
o Yes, please list 
 
 
 
 
 
 
 
 
 
 
Do any of your relatives have thyroid disease?   Please describe. 
 
 
 
Allergy History; 
Have you ever been told by a health professional (doctor or 
nurse) that you have nasal allergy, allergic rhinitis , or hay 
fever?   Yes     No 
Have you ever been told b a health professional (doctor or 
nurse) that you have asthma?                                                                
Yes     No 
Have you been symptomatic with asthma during the past year? 
(12 months from today)                                                                    
Yes      No 
Are you currently symptomatic?                                      
 Yes      No 
Are you currently using asthma medicine/                    
 Yes      No 
Have you had an asthma flare or worsening of symptoms 
requiring asthma medication during the past year? (12 months 
from today).     
                
 
Are you taking any 
prescription medications? 
o No 
o Yes, please list 
 
1. 
 
2. 
 
3. 
 
4. 
1. 
 
2. 
 
3. 
 
4. 
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Delivery Information: 
 
 
 
 
Date of 
baby’s 
birth? 
Sex of baby? 
o Male 
o Female 
Type of delivery: 
o Vaginal 
o Caesarean 
Any difficulties 
or 
complications 
with delivery  
o No 
o Yes 
If yes,please circle: 
Bleeding, Infections, 
Abscesses, Severe 
Hemorrhoids, other 
___________________ 
Length of labor: 
 
_________________ 
Are your currently breastfeeding? 
o Never breastfed 
o Partial (ounces per 
day:____________________) 
o Totally (never used formula) 
o Started then stopped 
Date stopped:__________ 
If Breastfeeding: 
Time of last feeding: 
______ am 
______ pm 
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Appendix B 
The Perceived Stress Scale 
 
         Stress Since We Last Visited with You       
Study ID #: _____________                                     Date: _________________ 
The questions in this scale ask you about your feelings and thoughts since we last 
visited with you. In each case, you will be asked to indicate how often you felt or 
thought a certain way.  Although some of the questions are similar, there are 
differences between them and you should treat each one as a separate question.  
The best approach is to answer each question fairly quickly.  That is, don’t try to 
count up the number of times you felt a particular way, but rather make a 
reasonable estimate.  
Please check the correct answer: 
1 = Never     2 = Almost never    3 = Sometimes     4 = Fairly often     5 = Very often 
 1 2 3 4 5 
How often have you been upset because of something that 
happened unexpectedly? 
     
How often have you felt that you were unable to control the 
important things in your life? 
     
How often have you felt nervous and “stressed”?      
How often have you dealt successfully with irritating life 
hassles? 
     
How often have you felt that you were effectively coping with 
important changes that were occurring in your life? 
     
How often have you felt confident about your ability to handle 
your personal problems? 
     
How often have you felt that things were going your way?      
How often have you found that you could not cope with all the 
things that you had to do? 
     
How often have you been able to control irritations in your life?      
How often have you felt that you were on top of things?      
How often have you been angered because of things that 
happened that were outside of your control? 
     
How often have you found yourself thinking about things that 
you have to accomplish? 
     
How often have you been able to control the way you spend your 
time? 
     
How often have you felt difficulties were piling up so high that 
you could not overcome them? 
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Appendix C 
The Profile of Mood States 
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